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ABSTRACT 
With rapid advances in the field of cellomics, genomics, and proteomics, the 
demands for development of enabling technologies for performing high throughput 
biological experimentation are ever increasing. Droplet based microfluidic systems 
have recently been developed to perform high throughput experimentations. With 
the ability to generate droplets over 1 kHz frequency and perform combinatorial 
experiments via various passive and active manipulating techniques, microdroplet 
technology provides an ideal platform for combinatorial biological experiments 
whilst consuming minimal amount of reagent. As it is possible to generate 
droplets, manipulate them, and characterise droplets using highly sensitive on-
line detection systems, it is now crucial to bring various functionalities together to 
create a micro total analysis system capable of performing complex biological 
experiments within microfluidic devices. 
As such, an integrated droplet based microfluidic platform was developed to assess 
the efficacy of photodynamic therapy against microbial organisms. Photodynamic 
therapy is an alternative efficacious treatment method for the treatment of 
localized microbial infections with several favourable features such as broad 
spectrum of action, efficient inactivation of multidrug-resistant bacteria, and low 
mutagenic potential. In order to perform the photosensitiser cytotoxicity screening, 
various microfluidic modules such as droplet generation, chamber based 
microdroplet storage and light irradiation, droplet reinjection, electrocoalescence 
and on-chip viability scoring of cells within droplets using a combination of 
carboxyfluorescein diacetate and propidium iodide were developed and integrated 
within the microfluidic platform. The microfluidic system was then used to screen 
the cytotoxicity of TBO against E.coli cells and the results were validated against 
conventional colony forming unit assays. Finally, the integrated system was used 
to assess the effects of several parameters on E.coli viability such as dark toxicity, 
photosensitiser concentration, light dose and poor oxygenation condition. 
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Chapter 1. Introduction 
1.1. Microfluidics 
Over the past 60 years, cell biology has enjoyed tremendous developments in 
terms of both the basic science and associated enabling technologies (1). The ever 
increasing biochemical information that has accompanied the advent of the 
postgenomic era has led to a need for high-throughput experimentation and 
sensitive analysis systems (2, 3). Conventional experimental tools suffer from 
large reagent consumption, insufficient throughput, and errors related to the 
transfer of sample between multiple instruments (3-5). 
In recent years, microfluidic technologies have emerged as potential high 
throughput platforms for performing various cell biological experiments. 
Microfluidic systems are able to process small volumes of fluid using channels 
with dimensions ranging from hundreds of nanometres to hundreds of 
micrometres (5). Microfluidic systems offer numerous advantages over 
conventional analytical devices, including faster analysis times, superior 
analytical performance, reduced sample/reagent consumption, reduction of 
instrument footprints, portability, and facile monolithic integration of functional 
components (4-6). Indeed, it is hoped that integration of different components in 
microfluidic systems will eventually lead to the realization of a micro total 
analysis system where all essential functions for an experiment are present in a 
microfluidic platform (3). 
1.2. Droplet microfluidics 
Droplet microfluidics has emerged as a promising platform for cell based 
applications (7-9). These devices utilize the flow instabilities of two immiscible 
fluids in microfluidic channels to create monodisperse water in oil (w/o) 
microdroplets (9, 10). These droplets, each of them equivalent to an individual 
reaction vessel, have the volumes of a few picolitres to nanolitres and can be 
generated at rates of up to several kHz whilst maintaining exquisite control over  
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Figure 1.1.  Microfluidic devices. (a) A microfluidic chemostat used to study the growth of 
microbial populations including a high density of pneumatic valves. Reproduced from 
reference 11. (b) LioniX  Microfluidic device. 
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both droplet size and composition allowing high throughput screening 
experimentations using minimal volume of reagents. Furthermore, it is possible 
to reduce solute surface interactions, cross contamination of reagents and Tayler 
dispersion and achieve rapid mixing which are often problematic in continuous 
flow formats (12-14).  
Many functional components for controlling droplets have been developed. For 
example, droplets can be generated (15), mixed (15), sorted (16-18), split (8) and 
merged with other droplets (19, 20). Moreover, droplets have been used for many 
applications such as protein crystallization (21), enzymatic binding kinetics (22), 
high throughput cytotoxicity screening (23), and single cell encapsulation 
experiments (24). 
1.2.1. Droplet formation 
As shown in Figure 1.1, T-junction and flow focusing geometries are frequently 
used for microfluidic droplet formation (15, 25). In these geometries, flow 
instabilities between two immiscible liquids cause droplet formation. In a T-
junction geometry, the aqueous phase and the oil phase are injected at right 
angles to each other and droplets form as a result of shear forces. Usually large 
sized plugs, blocking the whole channel, are formed in T-junctions whose volume 
can be changed by altering the channel width, relative viscosity of fluids and 
respective flow rates of the water and oil phases (15, 25). On the other hand, flow 
focusing geometries involve squeezing the continuous phase and the discrete 
phase through a small orifice where pressure and viscous stresses drive the inner 
fluid into narrow strands which then break off to form smaller droplets (25).  
1.2.2. Droplet manipulation 
Various methods of manipulating droplets have been developed by many groups. 
Droplets can be mixed, divided, fused, coded and sorted. There are passive and 
active ways of performing these operations. Passive methods employ various 
channel geometries to perform such manipulations while active methods use 
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active means such as electrohydrodynamic, and magnetic forces to manipulate 
droplets.  
Electrohydrodynamic forces can be broadly classified into two principles; 
electrocapillarity and dielectrophoresis. Electro-capillarity methods operate by 
distributing free charges on the interfaces between different phases and acting on 
the interfacial tension forces. Electrocapillarity is also referred to as continuous 
electrowetting, or electrowetting on dielectric. Continuous electrowetting acts on 
the interfaces and if the droplet is in contact with a solid electrode, it creates 
wetting force acting on the tri-phase contact line and changes the contact angle of 
the droplets. To prevent electrolysis at the electrode interface, an insulating layer 
is inserted between the fluid and electrodes. This is referred to as electrowetting 
on dielectric (26). Dielectrophoresis is a phenomenon where electrically neutral 
particles are polarised under a non-uniform electric field and the motion of the 
particle is affected by it according to their respective electrical permittivity 
compared to the medium (26). In this section, various droplet manipulating 
modules, both active and passive, will be introduced. 
Mixing 
Efficient mixing within microdroplets allows precise control of the reactions for 
various kinetic and biological studies (15). Fast mixing of droplets on the µs 
timescale (27) can be achieved by passing droplets through winding channels that 
induces chaotic advection which folds and stretches the droplet contents. 
Reorientation of droplets in winding channels and recirculation of the droplet 
contents by shear stresses create extremely narrow striations allowing rapid 
diffusion. Droplets can also be mixed using electric fields (8). 
Fission 
Droplets can be split by both passive and active methods (8). Fission of droplets 
allows control experiments to be performed in a parallel fashion. Passive fission 
incorporates channel designs that create shear forces to split the droplets into  
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Figure 1.2.  Convective droplet mixing within serpentine microfluidic channel. Reproduced from  
reference 13. 
controlled volumes. The volumes of the split droplets can be controlled by varying 
the flow rates of continuous phase and the channel resistances. Other methods of 
splitting droplets include droplet fission by EWOD (28).  
Fusion 
Controlled coalescence of droplets is an important operation in droplet based 
microfluidics. Both passive and active methods of merging microdroplets have 
been demonstrated by various groups. Velocity differences between different 
sized droplets (29), electrostatics (20), interfacial tension (30) and channel 
geometries (19, 31, 32) have been employed to induce droplet coalescence. Passive 
merging relies on the variations of channel geometries and other intrinsic 
physical parameters such as interfacial tension and droplet size. Tan et al. 
demonstrated droplet fusion with various channel expansion designs (31). 
Recently Niu et al. used pillar structures to hold the droplets and bring them in 
contact for merging (19). 
Active methods use electric fields to merge droplets (32-35). Such methods are 
particularly useful for surfactant stabilised droplets as it is normally not possible 
to fuse them using passive methods. Electrodes can also be used to charge the  
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Figure 1.3.  Droplet coalescence using pillar structures. Droplets get trapped in the chamber and 
coalesce with other incoming droplets. Scale bar indicates 100µm. Reproduced from 
reference 19. 
droplets upon generation and merge the oppositely charged droplets (34). 
Recently Cooper and co-workers have reported on-chip electrocoalescence of 
microdroplets that does not require precise electrode positioning nor droplet –
droplet synchronization by using four sets of electrodes (35). 
Sorting 
Sorting is an important operation for isolating droplets of particular interest, 
purifying samples and performing further operations on particular droplets. 
Various strategies for sorting have been demonstrated using different methods. 
Passive sorting refers to sorting droplets by continuously applying bias 
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throughout the operation and active sorting refers to operations where it is 
possible to sort droplets based on a variety of characteristics. In other words, the 
sorting criteria and mechanism are intrinsically coupled in passive sorting 
systems whereas they are not for active sorting systems (8). Size-based sorting 
using channel geometries has been demonstrated by Tan et al. (12). In this 
approach, the competition between the shear stress and flow rate of the channel 
is used to sort droplets of different sizes. Takayama and coworkers have also 
shown gravity driven microfluidic droplet separation (36). In addition, 
Dielectrophoresis based sorting (16), surface acoustic wave actuated sorting (37), 
pneumatic valve actuated sorting (38) and electrostatic actuated sorting (17) 
have been demonstrated by various groups. Sorting rates greater than 1.6kHz 
have been reported for dielectrophoresis based sorting systems and Baret et al. 
demonstrated an active fluorescence activated droplet sorting system based on 
enzymatic activity and achieved sorting rates of around 300 droplets per second 
with false positive error rates of 1 in 104 droplets (18). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4.  Fluorescence activated droplet sorting system using dielectrophoresis. Scale bar 
indicates 100µm. Reproduced from reference 18. 
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1.3. Droplet based microfluidics for cells  
Droplet microfluidic platform has unique advantages for performing cell based 
experiments (23, 39, 40). Firstly, it allows fast sensitive detection of secreted 
biomolecules from cells. In bulk experiments, secreted biomolecules from cells are 
instantaneously diluted by surrounding media which means that cellular activity 
from small number of cells cannot be observed efficiently. By compartmentalising 
cells in each droplet, the secreted biomolecules from cells accumulate inside the 
resident droplet and leads to faster analysis. 
Additionally, microdroplets allow stochastic confinement of cells in individual 
droplets. Stochastic confinement is a process where the whole sample is divided 
into many smaller volumes so that the number of the small volumes is larger 
than that of cells (39, 41). This essentially allows the encapsulation of single cells 
within individual droplets and the study of potentially important heterogeneity of 
individual cells and the analysis of rare cells by separating them from the whole 
population.  
1.3.1. Cell encapsulation 
For high throughput analysis of cells, cells have to remain viable and active 
within microdroplets during encapsulation process and after the required 
incubation period. Merten and his co-workers demonstrated survival and 
proliferation of Jurkat, HEK293T and c.elegans in microdroplets over several 
days (7). They reported above 80% survival rate of HEK293T cells for the first 4 
days and recultivation experiments demonstrated the recovery of fully viable and 
normally proliferating HEK293T cells after 2 days of encapsulation. These 
droplets were successfully reintroduced into a microfluidic device after various 
incubation periods to measure expression of a reporter gene. 10 – 20% loss of 
viability during encapsulation process due to shear stress was also observed by 
Brouzes et al (42). 
To fully exploit droplet based microfluidic systems for cell biology, encapsulation 
of cells in droplets with control over cell occupancy and droplet size is crucial. 
9 
 
Single cell encapsulation is particularly important for studying heterogeneity of 
individual cells more accurately in systematic way. Various methods have been 
used to control cell occupancy in droplets such as stochastic loading at low cell 
density (39, 41), optical trapping (43), bio electrospraying (44), and inertial 
focusing(24). When cells are encapsulated in droplets, the cell occupancy in 
droplets typically follows Poisson distributions. If the concentration of cells is 
controlled so that only 15% of droplets are allowed to contain single cells, then 
only 0.5% of droplets would contain multiple cells. This allows studying 
stochastic expressions of single cells. Gene expression, phenotypic variation, 
quorum sensing and screening of protein libraries for in vivo directed evolution 
have been demonstrated in microdroplets at single cell level using stochastic 
confinement (40, 41, 45-47). Daniel Chiu and his co-workers demonstrated 
selective encapsulation of single cells in femtolitre droplets by optical methods 
(43). In this work, they generated femtolitre sized droplets, and selectively 
encapsulated single cells and organelles by optically trapping and transporting 
them to the aqueous/oil interface.  
Although stochastic confinement and optical trapping methods allow single cell 
encapsulation, they suffer from inefficient cell loading due to large number of 
empty droplets. It is possible to further overcome this limitation by controlled 
single cell encapsulation which allows efficient non-stochastic single cell loading 
in droplets for single cell analysis by using microfluidic hydrodynamic inertial 
focusing to achieve single cell encapsulation in monodisperse droplets (24). By 
flowing cell suspensions through a narrow micro channel at high flow rate, cells 
hydrodynamically interact with each other to form an evenly spaced zigzag 
shaped stream. The authors demonstrated single cell encapsulation at high cell 
density by matching droplet generation frequency with the inter-cellular 
distances. 
Droplet based microfluidic systems have also been used to generate alginate 
beads(48, 49) and agarose microparticles(50) containing living cells. Alginate 
microbeads serve as a matrix for cell immobilization as they are biocompatible,  
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Figure 1.5.  Single cell droplet encapsulation using inertial cell focusing. Cells are spaced apart 
evenly using inertial hydrodynamic force and encapsulated into droplets in a controlled 
manner. Reproduced from reference 24. 
nonimmunogenic, and semipermeable allowing cell culture in a three 
dimensional environment and can be used for therapeutic purposes (51, 52). 
Smaller beads offer several advantages such as easier transportation, limited 
dispersion, increased mechanical strength, and easier injection, and it is possible 
to create smaller beads with narrow size distributions using microfluidic systems 
(48, 49). Choi et al. generated monodisperse alginate microbeads, with sizes 
ranging from 60 to 95 µm, containing yeast cells in microfluidic device by mixing 
the sodium alginate and calcium chloride solutions (48). They also characterized 
the droplet formation process using n-hexadecane as a career fluid and identified 
stable droplet formation region for such viscous solutions at different capillary 
number and flow rate. After generation of microbeads, the viability of the 
encapsulated yeast cells were tested by encoded GFP expression. Kang and his 
co-workers achieved further enhancement in sustaining cell viability by adopting 
external gelation method where alginate droplets containing mammalian cells 
were generated and gelified in oleic acid infused with calcium and the toxic oleic 
acid was quickly exchanged with non-toxic mineral oil(49).  The viability of the 
encapsulated P19 embryonic carcinoma cells were increased up to 90% and the 
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encapsulated cells were successfully cultivated for 7 days to demonstrate 
proliferation of cells within microbeads. Recently, monodisperse agarose 
microparticles containing bacterial cells were created using droplet based 
microfluidics, the minimum inhibitory concentration of rifampicin was 
determined and spontaneous mutants with resistance to the antibiotic were 
isolated and characterized by DNA sequencing (50).  
1.3.2. The choice of oil and surfactant 
In order to perform complicated cell based microfluidic applications, it is necessary 
to use a robust, biocompatible surfactant. Often, droplet microfluidics researchers 
suffer from limited choices of the suitable oil and surfactant combinations 
available. It is vital to have excellent long term droplet stability to integrate 
various functional components on chip as unintended breakage and coalescence of 
droplets can lead to cross-contamination of the reagents, lack of control over 
droplet compositions, and varying droplet sizes. Droplet breakage depends heavily 
on the relative viscosity of oil and water phase which contribute heavily to the 
shear stress which is the driving force (53). To prevent droplet breakage, 
oil/surfactant with low viscosity is advantageous as it reduces the shear stress 
acting on droplets. Uncontrolled merging of droplets also presents a challenge. To 
avoid this, surfactant is often added to lower the interfacial tension. In particular, 
perfluorinated di-block copolymer surfactants provide excellent droplet stability as 
they have long fluorocarbon tails which sterically hinders droplet interfaces from 
coming into contact with each other (54).  
Also, the effects of the oil and surfactant on cellular processes should be 
considered. The interaction of biological molecules such as protein and DNA with 
the oil interface often leads to deactivation, denaturing, and localization of 
biological molecules at the interface (55). This problem can be alleviated by using 
non-ionic head groups on the surfactant to reduce interaction with biological 
molecules (54, 55). Leakage of biological molecules into the oil phase can lead to 
insensitive detection, inconsistent experimental results and cross contaminations 
between droplets. Thus it is important to use a continuous phase which is both 
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hydrophobic and lipophobic to prevent biomolecules from crossing over from 
aqueous to oil phase (54, 56-58). Oil and surfactant toxicity on cells should also be 
considered and Samuels and his co-workers reported around 15 % loss in cell 
viability with fluorocarbon oil as a carrier fluid which may be due to the shear 
stress inflicted upon the cells during encapsulation process (42).  
1.3.3. Enzymatic assay 
In bulk experiments, secreted molecules from cells are diluted by surrounding 
media which means that cellular activity from small number of cells cannot be 
observed efficiently (39, 41). By compartmentalising cells in each droplet, the 
secreted biomolecules from cells are retained in the resident droplet and allows 
high throughput detection of enzymatic activity of individual cells in pL-volume 
reaction vessel. Several groups demonstrated cell-based enzymatic activity assay 
in microdroplets (14, 18, 22, 43, 45, 59). Huebner et al. demonstrated 
quantitative cell based enzyme assay in microdroplets in high throughput 
manner for the first time (22). Alkaline phosphatase expressed in the periplasm 
of Escherichia coli cells was used as a model system and enzyme activity kinetic 
studies were performed based on thousands of droplets. Shim et al. monitored 
monomeric red fluorescent protein (mRFP1) and the enzymatic activity of 
coexpressed alkaline phosphatase in compartmentalized E.coli cells 
simultaneously (59). 
Compartmentalisation of cells in microdroplets allows colocalization of genotype 
and phenotype and provides the basis for selecting active catalysts from a library 
of mutants for high throughput directed evolution (22). Griffiths group recently 
developed fluorescence activated droplet sorting technology that sorts droplets at 
rates up to 2000 droplet s-1 (18). Weitz group, collaborating with Griffiths group, 
demonstrated high- throughput screening in drop-based microfluidics for directed 
evolution as shown in Fig. 1.6 and Fig. 1.7 (45). Using microdroplets, the authors 
screened 108 individual enzyme reactions in only 10 hours using less than 150 µL 
of total reagent volume which is a 1000-fold increase in speed and a 1-million fold 
reduction in cost compared to state-of-the-art robotic screening systems. 
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Figure 1.6.  Ultrahigh-throughput microfluidic screening platform for directed evolution (A) 
Droplet generation device. (B) A suspension of yeast cells displaying the HRP on their 
surface and the fluorogenic substrate AUR are encapsulated in droplets and (C) 
incubated for 5 minutes within an incubation line. (D) After incubation, the droplets 
display fluorescence signal arising from the yeast enzymatic activity. (E) The droplets 
are dielectrically sorted according to their fluorescence signal. Reproduced from  
reference 45. 
 
 
 
 
 
 
 
Figure 1.7.  Schematic of droplet based directed evolution experiment. (A) The wild type HRP gene 
is encoded on a plasmid and expression is driven by an inducible promoter. (B) Two 
libraries, having 10
7
 variants are created and (C) the libraries are transformed into yeast 
strain EBY100. (D) The yeast and nonfluorescent substrate are coencapsulated into 
droplets and (E) the substrate is converted to its fluorescent oxidation product in the 
incubation line. (F) After sorting the brightest droplets, the cells are released from the 
drops and the whole process is repeated to sort for the highest activity.  Reproduced 
from reference 45. 
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1.3.4. High throughput cytotoxicity screening 
High throughput cytotoxicity screening is a key step for drug discovery process 
for target validation and toxicity testing (60). As large proportion of the drugs fail 
as a result of toxicity, it is important to test toxicity of drugs efficiently in the 
drug discovery process (2). The ability to carry out cytotoxicity assays in high  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8.  High throughput screening platform for drug screening in droplet based microfluidics. 
A. Coded droplet generation containing various drug concentrations, B. Coalescence 
of drug containing droplets with the cell containing droplets, C. Incubation, D. 
Electrocoalescence of viability assay containing droplets with those containing drug 
treated cells for viability scoring. Reproduced from reference 61. 
 
15 
 
throughput manner using minimal amount of reagents will enable toxicity tests 
and target validation to be performed as early in the drug discovery process as 
possible and save time and effort. Conventional high throughput screening 
platforms are generally expensive and labor-intensive and suffer from rapid 
evaporation of reagents with increasing throughput (3). Microdroplets are well 
suited for performing high throughput cytotoxicity assays as it allows individual 
assays to be performed in picolitre droplets containing individual cells and 
reagents in high throughput manner.  
Recently, Brouzes et al. developed a droplet-based microfluidic platform for high 
throughput screening of human monocytic U937 cells using fluorescent viability 
indicators (42). The authors designed an integrated microfluidic system that 
includes encapsulation of single cells, incubation, droplet coalescence, automated 
optical coding strategy for drug concentration identification in droplets, and cell 
cytotoxicity screening. When cells are encapsulated in small volumes so that cell 
loading is less than one cell per droplet, effective cell density in each droplet 
increases which allows rapid and sensitive detection of susceptibility to 
antibiotics even at low cell density. Such sensitive detection may be utilised to 
provide rapid and effective patient-specific treatment of bacterial infections (41, 
62).  
Ismagilov and his co-workers demonstrated rapid bacterial drug susceptibility 
screening in microdroplets (41). Using droplet based microfluidics, the 
antibiogram of methicillin-resistant Staphylococcus aureus to many antibiotics 
was determined, minimal inhibitory concentration of the drug cefoxitin was 
measured, and sensitive and resistant strains of S.aureus in infected human 
blood plasma samples were successfully distinguished. Recently, asynchronous 
magnetic bead rotation based approach for measuring susceptibility has also 
been demonstrated (62). By encapsulating beads in droplets, the authors 
managed to reduce the interaction between magnetic beads and surface and 
determine susceptibility of E.coli to antibiotics more efficiently and accurately 
compared to conventional magnetic bead based susceptibility measurements. 
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1.4. Photodynamic Therapy 
In 1900, Oscar Raab reported induced cell death subsequent to light interacting 
with acridine red (63). His supervisor, Professor Herman von Tappeiner later 
described the phenomenon as photodynamic action. He also identified that oxygen 
was the key component in the photosensitisation reaction. Since then, 
photodynamic therapy (PDT) has been used to treat various different types of 
disease such as cancer (64), periodontal diseases (65), and localized microbial 
infections(66). Three components are required for photodynamic therapy; a 
photosensitiser, oxygen and a light source (67). 
1.4.1. Mechanism of PDT 
When light is absorbed by a photosensitiser, the molecule is excited to a singlet 
excited state. It then undergoes a transition to the triplet excited state via 
intersystem crossing or decays back down to the ground state via radiative or non-
radiative relaxation pathways. After the formation of the triplet excited state, 
there are two mechanisms for photodynamic action that can cause cell death.  
 
 
 
 
 
 
 
 
Figure 1.9.  The mechanism of the photodynamic action. Ps
1
, Ps
1*
 and Ps
3*
 represent photosensitiser 
in singlet state, singlet excited state and triplet state respectively. Reproduced from 
reference 68. 
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In the type I pathway, the triplet state undergoes redox reactions directly with the 
substrate. In this case, the photosensitiser reacts with a target by hydrogen or 
electron transfer. It can form hydrogen dioxide or superoxide anions by reacting 
with oxygen afterwards (69). 
 In the type II pathway, highly cytotoxic singlet oxygen is formed by energy 
transfer from the excited photosensitiser and singlet oxygen causes cell death by 
oxidation of vital components of the cell (68). Oxygen is an excellent quencher of 
excited electronic states. Singlet oxygen is highly electrophilic, strongly interacts 
with numerous cell enzymes and causes glycogenolysis inhibition, cell hypoxia, 
protein synthesis inhibition and DNA alteration. Also because of its short lifetime, 
its effects are localised to the vicinity of the photosensitiser (69). 
1.4.2. Photosensitizers 
Typical photosensitisers such as phenothiazines, porphyrins and phthalocyanines 
include aromatic rings.  Basic chemical structures and typical substituents are 
shown in Figure 10.  
 
 
 
 
 
 
 
 
Figure 1.10.  Basic chemical structures of phenothiazine, porphyrin, and phthalocyanine 
photosensitisers, and typical cationic peripheral substituents (R) Reproduced from 
reference 66. 
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The efficacy of a photosensitiser depends on various factors such as the 
photosensitiser’s triplet quantum yield, triplet state lifetime, singlet oxygen 
quantum yield, absorbance range, photosensitiser localization and site of action.  
Aromatic rings based on porphyrin structures are incorporated in the 
photosensitiser structure to stabilise the triplet excited state. In fact, Takemura et 
al. (70) have shown that as the triplet state quantum yield and lifetimes increase, 
phototoxicity also increases. In other words, higher triplet quantum yields and 
lifetimes of the photosensitiser give rise to an increase in the singlet oxygen 
quantum yield as well as giving more time for the photosensitiser to react with the 
substrates instead of returning to the ground state. 
The absorbance spectrum of the photosensitiser is also important. Many 
endogenous human tissues absorb below 700nm and light sources with low 
wavelength emission cannot penetrate the tissue deeply. A wavelength range of 
650nm to 900nm is ideal for a photosensitiser because the absorbance of the tissue 
is lowest in this region (71). 
 
 
 
 
 
 
 
 
Table 1.1.  Absorption maxima for various types of photosensitisers. Reproduced from reference 
68. 
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The photosensitiser should be able to penetrate through the cell membrane in 
order to have a cytotoxic effect. The effects of the charge on the photosensitizer 
have been investigated for gram positive and gram negative bacteria. Both gram 
positive and gram negative bacteria have a porous outer cell wall and cell 
membrane but gram negative bacteria possess an additional negatively charged 
outer membrane which has a very heterogeneous composition containing proteins 
with porin function, lipo-polypolysaccharide trimers and lipoproteins. This outer 
membrane inhibits the penetration of photosensitisers into the cell (66). Only 
small hydrophilic compounds can diffuse through the porin channels. Cationic 
charge disrupts such a membrane by interaction with the negatively charged 
membrane and allows the photosensitiser to penetrate into the cell (72). Thus 
cationic photosensitisers have been shown to have a greater phototoxicity against 
gram negative bacteria than anionic or neutral photosensitisers while gram 
positive bacteria are less affected by the charge on the photosensitisers (66). 
Hydrophobicity of the photosensitisers has also been shown to play an important 
role in penetration into the cell (73).  
Different photosensitisers have different sites of action. For example, Toluidine 
Blue O (TBO) is membrane active while methylene blue acts on DNA and break 
strands of DNA upon exposure to light (68).  
 
 
 
 
Table 1.2.  Site of action for different photosensitiser types . Reproduced from reference 74. 
1.4.3. Photosensitiser Screening 
Different photosensitisers have been tested against various different types of the 
cells. Most of these studies have been performed by measuring colony forming 
units. A cationic (tetra-N-methyl-pyridyl)porphine (T4MPyP) and an anionic 
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meso(tetra-4-sulphonatophenyl) porphine (TPPS4) have been tested against E.coli 
(Gram(+)) and E. Seriolicida (Gram(-)) cells. It has been shown that cationic 
photosensitisers had a much greater effect especially against gram positive E.coli 
cells (66). Streptococcus mutans were tested against TBO and under 65nM of TBO 
and 24J of irradiation, 70% of the bacterial cells were inactivated (75). 
1.4.4. Light sources 
Both coherent and non-coherent light sources have been used for photodynamic 
therapy. All light sources have achieved significant inactivation of several 
different bacteria types such as E.coli, S.aureus and C.albicans (69). As the 
penetration of the light into most biological tissues increases at longer wavelength, 
the ideal absorption of a photosensitiser is between 400nm and 700nm range (74). 
When choosing a light source, it is important to tune the emission to the 
absorption spectrum of photosensitiser. In this respect, a continuous light source 
may be more advantageous for screening different photosensitisers having 
different absorption maxima. On the other hand, lasers provide much higher 
powers and are monodirectional giving high levels of control. The 
monochromaticity permits irradiation with the exact wavelength at which the 
photosensitizer has its absorption maximum. Also, the coherence offers the 
possibility of delivering the light through optic fibres to the contaminated areas of 
the body (69). 
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Figure 1.11.  Cytotoxicity of photosensitisers against microorganisms. (a) The effect of irradiation 
time on the photodynamic efficacy against E.coli and E.seriolicida by TPPS4 and 
T4MPyP (b) The effect of phthalocyanine concentration on trophozoites and cysts. 
Reproduced from reference 66. 
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1.4.5. Dark toxicity 
Many photosensitisers have cytotoxic effects under dark conditions. For example, 
methylene blue has been shown to have dark toxicity against EMT-6 mouse 
tumour cells at high concentrations (76). Dark toxicity of TBO for streptococcus 
mutans is shown below in Fig.12 (75). 
 
 
 
 
 
 
 
Figure 1.12.  Dark toxicity of TBO against streptococcus mutans. (a) Dark toxicity, (b) with light 
irradiation. Reproduced from reference 75. 
1.4.6. Antimicrobial photodynamic therapy 
PDT is an attractive treatment module for various types of cancer such as skin 
cancer, breast cancer, bladder cancer and lung cancer (64). Tumour cells 
accumulate photosensitiser more than normal cells and selective destruction of 
cancer cells is possible. Also because photodynamic therapy requires light 
irradiation for cytotoxic effects, localised treatment is possible leading to fewer 
side effects than chemotherapies (64). PDT also causes apoptosis in tumours and 
recently it has been suggested that PDT can influence anti-tumour immunity (77). 
PDT has also been used for treating oral cavities (65), removal of dental plaques, 
gum disease (78) and localised microbial infections (68). Typically, it is necessary 
to give enough time for the photosensitiser to accumulate within the cells. It is 
usually necessary to incubate the bacterial cells around 30 minutes while for the 
eukaryotic cells, longer incubation time is usually required. The dark incubation 
 
(a) (b) 
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time varies for different photosensitisers and cell lines. One of the main 
limitations of PDT in the treatment of cancer is the limited penetration of light 
into the tissue for treating deep tissues. Thus the treatment of cancer using PDT 
has been limited to only a few types of cancers where light can be irradiated.    
1.5. Project Aim 
As droplet microfluidic technology continues to mature, it is possible to perform 
fundamental microdroplet manipulations that are essential for performing 
complicated high throughput experimental schemes (8, 20, 31, 37, 44). In 
addition, sensitive microdroplet detection technologies such as confocal 
fluorescence detection (27, 40, 61, 79), surface enhanced raman scattering (80), 
electrochemical detection (34, 81), and mass spectrometry (82) have been 
explored. Combining these functionalities together, there have been several 
studies where complicated droplet based high throughput screening experiments 
were performed on microfluidic devices (23, 45).  
Herein, we apply microfluidic technology to perform high throughput 
photosensitiser screening experiments. Firstly, various droplet manipulating 
techniques were integrated within microfluidic platform such as facile droplet 
generation, exposure of light onto microdroplets within microfluidic device, and 
detection of the cell viability on-chip. This microfluidic platform was designed to 
screen for various different parameters on cell viability such as light exposure 
conditions, photosensitiser concentrations, dark toxicity, and dissolved oxygen 
content. 
Initially, a perfluorinated tri-block copolymer surfactant capable of performing 
complicated reactions within microfluidic platform was synthesized and 
characterized in terms of facile droplet formation, stability against coalescence or 
flocculation, lipophilicity and biocompatibility (Chapter 3). Then the droplet 
formation was characterised so that stable droplets with controlled size and 
composition were generated using various oil and surfactant mixture at a wide 
range of droplet generation frequency (Chapter 3). Then, microfluidic droplet 
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manipulating modules including droplet storage chamber for light exposure, 
droplet reinjection system, droplet electrocoalescence and droplet incubation 
channel were developed and characterised for integration into the microfluidic 
platform (Chapter 4). A viability assay combination for on-chip cytotoxicity 
screening was developed and characterised in detail (Chapter 5). Finally, the 
whole system was combined together to perform high throughput photosensitiser 
screening on droplet based microfluidic platform and the results were compared 
with conventional screening methods such as micro wellplates and colony 
forming unit assay to prove the versatility and the accuracy of the microfluidic 
platform (Chapter 6).  
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Chapter 2. Methodology 
This chapter describes the microfluidic device fabrication and the detection 
system for high throughput screening applications. The devices are fabricated 
using variety of materials such as polydimethylsiloxane (PDMS), thermoset 
polyester and glass using rapid prototyping soft lithography and glass 
micromachining techniques. In addition, the confocal fluorescence spectrometer 
used in the droplet experiments for sensitive detection is described in detail.  
2.1. Microfluidic Device Fabrication 
Many variety of materials such as PDMS, glass and thermoplastic polyester 
derivatives have been explored for fabricating microfluidic devices for industrial 
mass production and laboratory level research purposes. Currently, the most 
widely used material for fabricating droplet based microfluidic devices for cell 
based applications is polydimethylsiloxane (PDMS) (1). PDMS has many intrinsic 
properties that are suitable for cell based applications in microfluidic devices; it is 
inexpensive, gas permeable, biocompatible, and optically transparent with low 
autofluorescence. In addition, PDMS microfluidic devices are fabricated using soft 
lithographic technique which allows microfluidic systems to be designed and 
fabricated rapidly (2). However, PDMS has several drawbacks such as poor 
chemical compatibility with many organic solvents, unstable surface modification 
over time, weak bonding strength and deformation of microfluidic channels under 
high pressure (3).  
On the other hand, glass/silicon microfluidic devices have high bonding strength 
and a wide range of solvent compatibility (4). However, wet-etching based 
fabrication procedure for glass micro-patterning is time consuming, technically 
demanding and expensive limiting its uses for rapid prototyping and 
industrialization. Recently, thermoplastic polymers such as poly(methyl 
methaacrylate) (PMMA), cyclic olefin copolymer (COC), and thermoplastic 
polyester (TPE)  have been employed for various applications (5). These polymers  
30 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1.  Equipments that were used to fabricate microfluidic devices. (a) Spin coater, (b) UV 
exposure, (c) Hot plate, and (d) Plasma oven. 
yield durable, strong microfluidic devices with good solvent compatibility and 
allow fast prototyping through polymer casting methods (3). The lack of gas 
permeability for the above materials means that they may not be suitable for some 
applications requiring long incubation time of droplets containing cell suspensions 
within microfluidic devices. 
In this thesis, PDMS, TPE and glass were used to fabricate microfluidic devices 
using soft lithography polymer casting and micro-machining techniques,   
respectively. Various equipments used for fabricating microfluidic devices are 
shown in Figure 2.1; (a) Spin-coater (Laurell Technologies Corp, USA), (b) UV-
exposure (OAI, San Jose, U.S.A), (c) Hot plate (Bibby Scientific Ltd., USA), and (d) 
Plasma cleaner (Harrick Plasma, USA). The detailed fabrication procedures for 
different micromachining methods are described later in this chapter. 
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Figure 2.2. Masks used for UV exposure (a) Film Mask, (b) Chromium photomask. 
 
 
 
 
 
 
 
Figure 2.3.  Chromium Mask Fabrication Process.   
2.2. PDMS microfluidic device fabrication 
PDMS microfluidic devices were fabricated using standard soft lithographic 
techniques. Microchannels were designed using AutoCAD program and the 
patterns were printed on a film mask (Micro lithography services Ltd, Essex, UK) 
based on the CAD design. Then the patterns on the film mask were transferred to 
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the chromium mask (Nanofilm, Westlake Village, USA) consisting of three layers 
for micro-patterning; a glass substrate, chromium layer, and AZ1518 photoresist. 
UV irradiation was directed onto the chromium mask and the positive 
photoresist layer was exposed to UV irradiation through the film mask (Figure 
2.2.(a)). Subsequently, chromium layer was etched according to the exposed 
pattern to produce a chromium photomask (Figure 2.2.(b)). Then, a negative 
photoresist (SU-8 50, MicroChem Corporation, USA) was spin-coated onto a 
silicon wafer (IDB Technologies Ltd, UK). UV light was exposed onto the SU-8 
coated silicon wafer through the patterned chromium mask and SU-8 was 
developed according to the pattern. Finally, PDMS (Dow Corning Ltd., Coventry, 
UK) was poured onto the silicon wafer and cured on the hot plate. PDMS block 
was then peeled off and bonded to the bottom PDMS layer through thermal 
bonding. Because these fabrication processes only take short period of time and 
the fabricated SU-8 moulds can be used many times for PDMS device fabrication, 
soft lithography allows for a quick turnaround from design conception to device 
operation. 
2.2.1. Chromium mask fabrication 
The fabrication process for the chromium photomask is outlined in Figure 2.3. 
Microfluidic layouts were designed using AutoCAD program and printed on a 
film mask. Before making an SU-8 master, a chromium mask was fabricated to 
preserve the film mask as it is mechanically stable and easy to clean. AZ1518, a 
positive photoresist, was used for patterning the chromium mask. It contains 
photo-active diazonaphthoquinone (DNQ) and novolak as shown in Figure 2.4.(a) 
and (b), respectively (6). Upon UV exposure, DNQ undergoes a series of radical 
chemical processes and makes the resin more soluble in alkaline solutions. Thus, 
the exposed part dissolves in the developer while the unexposed part remains 
essentially invariant during the development process.  As shown in Figure 2.3, 
the film mask was placed on top of the photoresist part of the chromium 
photomask making sure that the emulsion side of the mask makes solid contact 
with the chromium mask. Glass slide was placed upon the film mask to make  
33 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4.  Chemical structures of photoresists (a) DNQ and (b) Novolak. 
sure solid contact between them. Then, AZ1518 coated chromium mask was 
exposed with UV irradiation (OAI, San Jose, U.S.A) through film mask for 11 
seconds at 10mW/cm2. The exposed chromium mask was then developed for two 
minutes to strip off the exposed photoresist using a mixture of the photoresist 
developer (Microposit 351 developer, Chestech Ltd, UK) and deionized water at a 
1:5 volume ratio. Then the developed chromium mask was thoroughly cleaned 
using water and etched using the chrome etchant solution (Aldrich, UK) to 
remove the chromium layer under the developed area for 5-10 minutes. The 
patterned chromium mask was rinsed using DI water and placed in acetone to 
strip off the residual photoresist on the glass substrate. If some residual 
photoresist remained on the substrate, the glass substrate was sonicated in 
acetone for a few minutes to completely remove the photoresist. 
2.2.2. SU-8 patterning on silicon substrate 
SU-8 (MicroChem, Chestech Ltd, UK), a widely used negative photoresist, was 
used as a structural photoresist material for making the template for PDMS  
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Figure 2.5.  Patterning SU-8 mold on silicon wafer. 
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based microfluidic devices. It offers mechanically strong structures with good 
chemical stability with many acids and bases as well as having high 
transparency to near -UV and visible light (7). SU-8 contains Bisphenol A 
novolak epoxy oligomer and a photoinitiator such as triarylsulfonium 
hexafluoroantimonate salt. SU-8 undergoes a high degree of cross-linking after 
photoactivation of a photoacid which makes the microstructures stable and 
allows robust patterning of vertical microstructures of varying sizes as a 
template for PDMS microfluidic devices. SU-8 photoresist is available in a wide 
range of formulations with varying viscosities which allow patterning 
microstructures with different thicknesses. SU-8 patterning on the silicon wafer 
consists of three simple steps; Spin-coating, UV exposure, and development as 
shown in figure 2.5.  
2.2.2.1. Spin-Coating 
Spin-Coating is typically used to spread SU-8 on the silicon master. To ensure 
high quality SU-8 coating, the base substrate was thoroughly cleaned using 
methanol, rinsed with Millipore water and placed in a piranha solution bath 
which consists of a 3:1 mixture of sulfuric acid and hydrogen peroxide. Just 
before spin-coating, the silicon wafer was rinsed with water and dehydrated on a 
95°C hotplate. Approximately 3 grams of SU-8 was carefully poured onto a silicon 
wafer (IDB Technologies Ltd, UK) avoiding bubble formation during this step. 
The silicon wafer was then initially spun at 500 rpm for 10 seconds to spread SU-
8 over the entire wafer area then ramped up to 1000-3000 rpm at an acceleration 
rate of 252 rpm/second and maintained for 30 seconds in order to obtain the 
desired thickness of the SU-8 layer. The formulation viscosity and the spinning 
speed had a large effect on the thickness of the SU-8 layer and the thickness was 
measured after fabrication of each SU-8 mould. For example, SU-8 50 was spun 
at 3000 rpm for 30 seconds at an acceleration rate of 252 rpm/second to obtain 50 
µm thick layer. The wafer was then placed on a 65 °C hotplate for 5 minutes and 
95 °C for 30 minutes to cure the SU-8 film for UV exposure step.  
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2.2.2.2. UV Exposure 
After curing SU-8 on the silicon wafer, the SU-8 coated Si wafer was then 
exposed to UV light for 14 seconds at 20mJ/cm2 through the chromium 
photomask for 50 µm thick SU-8 pattern. The exposure time was particularly 
important as overexposure led to rugged channel structures while insufficient UV 
exposure led to insufficient cross-linking of SU-8. For different SU-8 thickness, 
the exposure time had to be tuned to obtain clean microfluidic patterns. After UV 
exposure, the wafer was then post-baked on the 65 °C hot plate for 1 minute then 
95 °C hot plate for 5 minutes. The post exposure baking process enhances the 
cross-linking of the SU-8 so that it doesn’t dissolve in the subsequent 
development processes. 
2.2.2.3. Development 
After cooling down, the wafer was placed in 2-methoxy-1-methylethyl acetate 
(Microposit EC solvent, Chestech, UK) for development. The time required to 
completely develop the unexposed SU-8 is dependent on the thickness, agitation, 
and the shape of microstructures. Typically, 5 minutes of developing time was 
sufficient for 50 µm thick structures. In order to check whether the development 
is complete, the wafer was rinsed with isopropanol as any unexposed SU8 turns 
into a white, flaky precipitate during the rinse. Further development of the wafer 
removes the white precipitate. Once the development was complete, the wafer 
was cleaned using hexane and methanol and blow dried with nitrogen gas. 
2.2.3 PDMS device fabrication 
The developed silicon master was then used as a mould for PDMS microfluidic 
devices (Figure 2.6). In order to strip off PDMS from the silicon master, it was 
necessary to hydrophobically coat the silicon wafer surface using perfluorooctyl 
trichlorosilane (Fluorochem, UK) under vacuum for 3 hours. Sylguard 184 silicon 
elastomer kit (Dow Corning Ltd., Coventry, UK) was used to fabricate the 
microfluidic devices. A siloxane oligomer and curing agent were mixed thoroughly  
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Figure 2.6.  PDMS microfluidic device fabrication. 
in a 10:1 ratio. After thoroughly mixing them, 40 grams of the mixture was 
poured onto the silicon wafer master placed in a square petri dish. The mixture 
was then degassed under vacuum and PDMS on the silicon wafer was cured on a 
hot plate at 65°C for 4 hours. After curing, PDMS was peeled off from the master 
and holes were punched in with a biopsy punch (kai Europe GmbH, Solingen, 
Germany) to connect tubing to microfluidic device. 
2.2.4 Channel Bonding 
Fabricated PDMS devices can be bonded to different bottom substrates: PDMS 
and glass (Figure 2.6). In order to bond channels to the bottom PDMS substrate, 
PDMS siloxane oligomer (tetra(trimethylsiloxy)silane) and curing agent mixture 
was poured onto an empty petri dish (6g) and degassed for 5 minutes. It was then 
placed on the hot plate at 65°C for approximately 18 minutes for half curing. The 
bottom plate and top PDMS block were then thermally bonded together by 
placing the top block on the half cured bottom layer. Then the device was 
completely cured in an oven at 65°C overnight. PDMS microfluidic channels can 
also be bonded to glass substrate. In this case, the fully cured PDMS blocks and 
glass substrates were washed with acetone and placed in a plasma oven. The 
glass substrates were cleaned with a piranha solution prior to bonding in order to 
obtain strong bonding between the two layers. After 1 minute of oxygen plasma 
treatment at high power, the PDMS top block was placed on the glass slide for 
bonding. The bonded pdms-glass chips were placed on the hotplate for 10 minutes 
to strengthen bonding between them. 
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2.2.5. Multilayered PDMS Device 
In order to fabricate multilayered PDMS based microfluidic devices, the fluidic 
channel and pillars were fabricated using polydimethylsiloxane (PDMS) by 
standard soft lithographic techniques. More specifically, to fabricate the 
microfluidic chip, PDMS base and curing agent (Sylgard 184; Dow Corning, 
Wiesbaden, Germany) were mixed in a ratio of 10:1 w/w, degassed, decanted onto 
SU8-on-Si wafer master (IDB Technologies Ltd, Wiltshire, UK) and fully cured 
overnight in an oven at 65 °C. After thermal curing, the PDMS layers were 
peeled off from the master, followed by inlet, interlayer connecting and outlet 
holes being punched with 1 mm sized punch (BIOPSY punch, Kay industries co, 
Gifu, Japan). These PDMS layers and a 1mm slide glass were plasma treated, 
aligned with respect to each other using optical microscope, bonded and placed on 
a hot plate to strengthen the bonding between each layer. 
2.3. Thermoplastic based microfluidic device fabrication 
PDMS mould was used to fabricate devices out of thermoplastic polyester (TPE). 
TPE based microfluidic devices are durable, chemically resistant and has a large 
burst pressure compared to PDMS chips. In fact, TPE based microfluidic devices 
can withstand pressures of up to 17.8 MPa compared to 1.2 MPa for PDMS 
microfluidic devices (5). Also, TPE material has large Young’s modulus compared 
to PDMS based devices and does not expand under pressure as much as PDMS 
based microfluidic devices. Thus it is well suited for high pressure applications 
where high burst pressure, low device expansion and stable microfluidic 
operations are required. As such, thermoplastic polyester material has been used 
for various applications requiring high pressure such as microfluidic HPLC 
devices coupled with droplet generation module as shown in Figure 2.7 (8). 
Care should be taken in the design of the thermoplastic based microfluidic 
devices as these devices will have the inversed channel structure compared to 
PDMS devices. In other words, channels have to be dark field in the film mask 
design while when designing for PDMS devices, the channels are bright field.  
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Figure 2.7.  TPE based microfluidic HPLC device used for separating fluorescent dyes such as 
fluorescein and Alexa fluor 488. This device is capable of withstanding the burst 
pressure of up to 17.8 MPa. Scale bar indicates 1 cm. 
2.3.1. PDMS mould fabrication 
PDMS mould was fabricated using the same soft lithography procedures as that 
for PDMS microfluidic devices. The PDMS mould was then peeled off from the 
SU-8 mould and surrounded with 4 mm thick PDMS walls to define the 
dimensions of the device. Also, small PDMS pillars were attached to the inlet and 
the outlet using PDMS as a glue to form holes that connect microfluidic devices to 
the tubing (Figure 2.8). 
 
 
 
 
 
 
 
Figure 2.8. PDMS mould for fabricating TPE based microfluidic devices. A degassed mixture of 
TPE and the curing catalyst was poured onto the mould from the glass vial. 
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2.3.2. TPE device fabrication  
TPE resin (CFS Fibreglass, UK) was mixed thoroughly with its polymerization 
catalyst, Methyl ethyl ketone peroxide (MEKP), in a ratio of 100:1 w/w, degassed, 
and decanted onto the PDMS mould (Figure 2.8). Then the TPE mixture on the 
PDMS mould was degassed under vacuum. During the degassing process, care 
should be taken as the mixture bubbles violently due to the gas permeability of 
PDMS material. Then the TPE mixture was partially cured for 10 to 20 minutes 
in an oven at 45-65 °C. Lower curing temperature was better for fabricating 
smaller microstructures as TPE shrinks during the curing process and deforms 
more rapidly at higher temperature. After partial curing, TPE block was peeled 
off from the PDMS mould and bonded to the oxygen plasma treated bottom 
substrate. Oxygen plasma renders the glass surface more hydrophilic and 
strengthens the bonding between the top and the bottom substrates. Different 
materials such as glass and TPE can be used as the bottom substrate. Then the 
bonded TPE block was cured at 65 °C overnight. In order to interface TPE devices 
to syringes, PEEK unions (Phenomenex, USA) were placed at the inlets and the 
outlets and bonded to the device using general purpose, room temperature curing 
epoxy (Vishay Measurements Group Ltd., UK). 
2.4. Glass Micromachining 
Glass based microfluidic devices are strong, chemically resistant, optically 
transparent and durable which make them appropriate for many applications 
requiring high mechanical strengths and chemical resistance. One of the crucial 
differences between PDMS based microfluidic devices and the glass based 
microfluidic devices is the profile of microchannels. This is because of the fact 
that wet isotropic etching is employed to fabricate glass based microfluidic 
devices as shown in Figure 2.10. In other words, the channel cross-sectional 
profile is approximately trapezoidal. 
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2.4.1. HF etching 
HF etching for fabricating glass microfluidic devices is time consuming, difficult 
and dangerous, requiring users to wear protective gear sets as shown in Figure 
2.9. Before beginning fabrication procedures, protective safety equipments must 
be worn and Ca(OH)2 solutions (Aldrich, UK) were prepared for HF 
neutralization. Glass microfluidic device fabrication involves three steps: 1. 
Chromium patterning on glass, 2. HF etching, and 3. Glass layer bonding. 
AZ1518 coated chromium borosilicate glass mask (Nanofilm, Westlake Village, 
USA) was used to fabricate microfluidic devices. Chromium masking layer was 
patterned as described in section 2.2.1 in order to make an open region for HF 
wet etching. 
The wet etching process was performed in an inert plastic container placed on a 
magnetic stirring plate (Bibby Scientific Ltd., UK). A mixture of etchants, 
containing 0.6% HF (Sigma-Aldrich, UK), 6.7% HCl (Sigma-Aldrich, UK) and 
1.4M NH4F (Sigma-Aldrich, UK), was prepared in the HF etching bath whilst 
constantly stirring with teflon plastic stirring bar. The patterned chromium 
masked substrates were placed in a plastic sample holder and immersed in the 
 
 
 
 
 
 
 
Figure 2.9.  Protection Equipments for HF etching. 
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Figure 2.10.  Isotropic wet etching of glass substrate. 
HF etching solution. Once fully etched, the glass slides were neutralized in the 
Ca(OH)2 bath and interconnecting holes were carefully drilled into the patterned 
glass slides using a Xenox drilling machine (Farnell, UK) with a 0.25 mm 
diameter tungsten carbide dental drill bit (Diama International Inc., UK). The 
remaining chromium on the glass substrate was then etched away using the 
chrome etchant solution (Sigma-Aldrich, UK). 
2.4.2. Glass device assembly 
In order to achieve good bonding between two glass slides, it is crucial to have 
clean surfaces on both sides. The patterned glass slides and bottom substrate 
glass slides were cleaned using the piranha solution overnight prior to thermal 
bonding. The two glass slides were then placed on top of each other in the glass 
bonding oven (Nabertham GmbH, Germany) and a small flat ceramic weight (300 
grams) was placed to ensure solid contact. The heating program for bonding was 
configured so that the oven was heated up to 555°C gradually throughout 6 hours 
and kept at 555 °C for 1 hour. Then, the temperature was further ramped up to 
585°C (1 hour) and maintained for 6 hours. Then the oven was cooled down to 
555 °C for one hour before finally cooling down to room temperature for 12 hours 
time period. After bonding, PEEK unions (VWR International, UK) were 
mounted on the inlet and the outlet of the device using a general purpose, room 
temperature curing epoxy (Vishay Measurements Group Ltd., UK). 
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2.5. Fluorescence Detection 
Fluorescence detection is a non-invasive and highly sensitive technique and is 
widely used for many biological analyses such as cell based assays(9), enzymatic 
assays(10), protein-protein interactions(11) and DNA analysis(12). It is 
particularly useful for biological microfluidic applications as microfluidic systems 
typically have small detection volumes and require highly sensitive detection 
techniques. Various different properties of fluorescence such as fluorescence 
intensity (9), lifetime (13), polarization (14) and fluorescence resonance energy 
transfer (11) have been utilised for microfluidic studies.  
2.5.1. Confocal Fluorescence Microscopy 
Confocal fluorescence microscopy is a highly sensitive detection method capable 
of detecting signals from single molecule and has been highly exploited in 
biological research. A confocal fluorescence microscope provides highly sensitive 
three-dimensional optical resolution by actively suppressing any signal coming 
from out of focus planes. The suppression of out of focus plane signals leads to 
low background signals. This is achieved by placing a pinhole in front of the 
detector.  In a confocal microscope, the specimen is typically excited using a 
collimated laser beam focused to a small tight spot by a microscope objective. 
Then the fluorescence emission from the specimen is directed to the detector 
through a series of dichroic mirrors, filter sets and pinholes. 
2.5.2. Custom made Confocal Detection System 
A custom made confocal detection setup was used for the droplet based 
experiments described in this thesis. Figure 2.11 shows the schematic diagram of 
the confocal fluorescence spectrometer used for the confocal fluorescence 
detection and the picture of the setup is presented in Figure 2.13. All the optical 
components such as the beam steering optics, an olympus IX71 microscope 
(Olympus UK Ltd, UK) and detectors were mounted on an optical table (Thorlabs, 
Ltd, UK). A 488nm diode laser (10mW, Coherent UK Ltd, UK) was used as the 
excitation source for all droplet based microfluidic experiments performed in this 
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thesis. Lasers are used for the confocal fluorescence detection as they are bright, 
highly monochromatic, and have Gaussian beam profiles. Also, 488nm 
wavelength is highly compatible with many of the fluorescent dyes used in the 
experiments in this thesis. A dichroic mirror (DC1: z488rdc, Chroma Technology 
Corp., USA) was used to selectively reflect the blue laser beam by 90° whilst 
letting red laser through without deflection. This allows one to make use of other 
laser sources with different wavelengths such as 632.8 nm HeNe laser if 
necessary although this option wasn’t utilized in this thesis. The neutral density 
filter set housed in a filter wheel (FW2A, Thorlabs, Ltd, UK) was placed in the 
laser pathway to attenuate the laser intensity. By rotating the filter wheel, 
appropriate optical density values can be selected for each experiment. An iris (I1: 
ID20, Thorlabs, Ltd, UK) was placed to provide a reference point for the height 
and direction of the laser pathway. Then the laser beam passed through a 5X 
beam expander (BE: BE05M-A, Thorlabs, Ltd, UK) with a maximum input 1/e2 
beam diameter of 2.25 mm. In other words, it expands the 488 nm laser beam 
from 0.7 mm to 3.5 mm after beam expansion. Through the use of the beam 
expander, the laser beam fills the entire back aperture of an objective lens which 
reduces the laser spot at the focal point as the size of the focused beam after the 
objective lens is inversely proportional to the incident beam diameter. Thus it 
allows one to minimize the detection probe volume and perform highly sensitive 
fluorescence detection. Two Mirrors (M1, M2: BB1-E02, Thorlabs, Ltd, UK) 
reflect the expanded laser beam into the microscope body and allow for the fine 
adjustments and alignment of the laser beam with respect to the microscope for 
sensitive fluorescence detection. Two Irises, I2 and I3, ensure the perfect 
alignment of the laser beam with respect to the microscope body. The incident 
laser beam is then reflected towards a high NA objective lens and focused onto 
the sample. A high NA objective was used for the experiments as it maximizes 
the fluorescence signals collected from the focal plane by minimizing the probe 
volume. Fluorescence signals from the sample then pass through the dichroic 
mirror, filtered by emission filter, and focused onto a tight spot by a tube lens 
prior to passing through a 75 µm precision pinhole (PH: P75S, Thorlabs, Ltd, UK)   
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Figure 2.11.  Confocal fluorescence microscope used for highly sensitive fluorescence detection. 
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Figure 2.12.  (a) Confocal Fluorescence detection setup for microfluidic experiments. (a) Picture of 
the confocal fluorescence detection setup (laser pathway). (b) 488 nm excitation laser 
source. (c) Attenuator for attenuating laser intensity. (d) Optical mirror pathway into 
the microscope for fluorescence detection with the beam expander for sensitive 
fluorescence detection. 
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mounted on a XY translation stage (ST1XY-A/M, Thorlabs, Ltd, UK). After 
passing through the pinhole, a dichroic mirror (DC3: z630rdc, Chroma 
Technology Corp., USA) transmits light with wavelengths above 630nm and 
reflects those below 630nm to split fluorescence signals into two detection 
pathways. Then a band-pass emission filter (em2: ET525/50m 25mmR, Chroma 
Technology Corp., USA) further filters light directed towards the green channel 
by transmitting wavelengths from 500nm to 550nm and blocking other 
wavelengths. In the red channel, a long pass emission filter (em3: hq640lp, 
Chroma Technology Corp., USA) transmits light with wavelengths greater than 
640nm whilst blocking those below 640nm. In both of the detection channels, 
plano-convex lenses (L1, L2: LA1951-A, f = 25.4 mm, 25.4 mm diameter, Thorlabs, 
Ltd, UK) focus light onto avalanche photodiode detectors (APD1, APD2: SPCM-
AQR-14, Perkin Elmer, Canada) connected to the data acquisition unit. 
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Chapter 3. System characterization 
This chapter presents the characterization of the droplet based microfluidic 
system for applications for high throughput screening. In particular, the 
development of robust surfactants for various microfluidic modules is presented. 
Commercial surfactants such as perfluorooctanol, ABIL EM-90, and Croda 
Cithrol DPHS were tested using the microfluidic devices. Then, a perfluorinated 
tri-block copolymer surfactant composed of PFPE-PEG-PFPE chains was 
synthesized and tested extensively for the suitability for high throughput 
screening experiments. Droplet generation process was also characterized using 
both T-junction and flow focusing geometries and the effects of water fraction, 
linear flow velocity and viscosity on the droplet formation processes are discussed 
here.  
3.1. Surfactant 
In order to perform complicated microfluidic droplet operations such as stable 
droplet generation, long time incubation, reinjection, and electrocoalescence, it is 
essential to use a robust surfactant (1). A surfactant is a surface active agent 
which stabilizes the interface between two phases such as oil and water. 
Surfactants are usually amphiphilic molecules with both hydrophobic groups and 
hydrophilic groups (2). Surfactants adsorb at the interface between oil and water 
and lower the surface tension of the interface which stabilizes droplets against 
coalescence. In the absence of surfactants, droplets coalesce together to reduce 
the free energy and the surfactants provide an energy barrier to stabilize the 
dispersion in a metastable state.  
As surfactants are essential parts of the droplet based microfluidic technology, 
they need to satisfy various properties in order to perform high throughput 
cytotoxicity screening. As well as stabilizing the microdroplet interfaces for a long 
period of time, they need to be compatible with the cells used for the experiments, 
be inert to the droplet content, control the molecular exchange between droplets 
and inhibit the biomolecule migration to the interface (1). The observation of 
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microdroplet flow within microfluidic devices provides valuable information on 
the emulsion properties and the interfacial rheology of surfactants. An array of 
microdroplet trapping structures was used in order to evaluate various properties 
such as droplet stability towards coalescence, breakage, and lipophilicity. Herein, 
various oil and surfactant mixtures including mineral oil derivatives, and 
perfluorinated oil/surfactant were tested for high throughput screening 
applications in microfluidics. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.  (a) Uncontrolled droplet coalescence of droplets in mineral oil with 2 % v/v ABIL EM-
90. Scale bar indicates 100 µm. (b) Droplet generation and uncontrolled coalescence of 
droplets in perfluorodecalin with 5% v/v 1H, 1H, 2H, 2H-perfluoro-1-octanol. Scale 
bar indicates 50 µm.  
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3.1.1. Commercial Surfactants 
Various commercially available oil and surfactant mixtures such as mineral oil 
with Abil EM-90, perfluorodecalin (Sigma-Aldrich, UK) with 1H,1H,2H,2H-
perfluoro-1-octanol  (Sigma-Aldrich, UK), and isopropyl myristate  with cithrol 
DPHS have been used for performing biological experiments in microfluidic 
systems (3, 4). The oil and surfactant mixtures were tested for the droplet based 
microfluidic applications. 
ABIL EM-90 (Surfachem, UK) is a large comb copolymer known for strongly 
stabilizing emulsions. It has a rigid poly(dimethylsiloxane) backbone with 
hydrophobic alkyl and hydrophilic ethylene/propylene oxide grafts. The molecular 
weight is 62000 dalton but neither the molecular weights of the various groups 
nor their distribution on the backbone is known. ABIL EM-90 is biocompatible 
and is currently being used in various cosmetic products (5). Within microfluidic 
fields, mineral oil with Abil EM-90 was used for digital PCR amplification in 
droplets (3), and directed evolution (6). Mineral oil (Sigma-Aldrich, UK) and Abil 
EM-90 combinations provide relatively stable microdroplets although droplets 
often undergo uncontrolled coalescence when pressurized against each other 
within a microfluidic channel (Figure 3.1.(a)). Furthermore, the high viscosity of 
the solution meant that the back pressure within a long incubation channel was 
too large which caused unstable droplet generation, and frequent device 
delamination. Due to unwanted droplet coalescence and high back pressure, 
ABIL EM-90 was unsuitable for microfluidic applications requiring long 
incubation time and complex fluidic operations.  
Perfluorodecalin and 1H,1H,2H,2H-perfluoro-1-octanol combination was used for 
studying protein crystallization by Ismagilov and his coworkers (4). The 
perfluorinated oil and surfactants are advantageous for microdroplet based 
biochemical applications as they are lipophobic, inert, insoluble in water and 
compatible with many biochemical molecules. (7). Unfortunately, droplets in 
perfluorodecalin oil with 1H,1H,2H,2H-perfluoro-1-octanol were not stable and 
merged with each other under pressure (Figure 3.1(b). 
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Croda cithrol DPHS is a nonionic triblock copolymer with a chemical structure of 
poly(12-hydroxystearic acid) - poly(ethylene oxide) - poly(12-hydroxystearic acid) 
(PHS-PEO-PHS). In essence, it consists of two hydrophobic chains and a 
hydrophilic chain. PHS chain is soluble in oil while PEO chain is soluble in 
aqueous phase. The conformation of the polymeric surfactant at the W/O 
interface is schematically shown in Figure 3.2. In addition to stabilizing the 
interface using the amphiphilic nature of the surfactant, it consists of long PHS 
polymeric chains which provide steric hindrance at the interface when droplets 
are pressed against each other.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.  Conformation of PHS-PEO-PHS polymeric surfactant at the W/O interface.  
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Figure 3.3.  (a) A concept picture of droplets within the microfluidic trapping structure array. (b) A 
droplet within the chamber array and the flow of the oil phase around the droplet. (c) A 
photograph of the microfluidic trapping chamber array used for testing the continuous 
phase formulation. Scale bar indicates 100 µm. 
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PHS-PEO-PHS surfactant was tested in various oil formulations such as light 
mineral oil (Sigma-Aldrich, UK), Isopar M (ExxonMobil, UK), and Isopropyl 
Myristate (Sigma-Aldrich, UK). An array of microfluidic trapping chambers was 
used for testing the surfactant performance within microfluidic devices (Figure 
3.3.(a), (b), (c)). In this microfluidic array, the droplets are introduced to the 
microdroplet parking chamber, and kept within the chamber until another 
incoming droplet pushes it out to the next chamber. While the droplets are in the 
chamber, the oil flows around the trapping pillars as shown in Figure 3.3.(b). The 
microdroplet flow within the microfluidic chamber allows the empirical 
assessment of the stability of droplets against coalescence, the rigidity of droplets, 
and lipophilicity of the continuous phase. 
Firstly, light mineral oil with 2% w/v DPHS was tested for the droplet stability. 
Although the droplets were stable with regards to the droplet coalescence, they 
were prone to droplet breakage within the microfluidic system. The droplet 
breakage within the microfluidic chamber was due to the high viscosity (13 cP) of 
the mineral oil and the surfactant as the continuous phase with higher viscosity 
is able to exert greater pressure on the droplets. Although the droplets were 
mostly stable against coalescence, occasional droplet coalescence events were still 
observed when pressed against each other. Figure 3.4.(a) shows the flow profile of 
the droplets inside the 96 microfluidic trapping arrays.  
Then, isopar M with 2% w/v DPHS was tested for then droplet stability. In terms 
of the inter-droplet coalescence and breakage, the oil/surfactant mixture showed 
an excellent stabilization property. No droplet coalescence or droplet breakage 
was observed even when the droplets were tightly pressed against each other. 
However, the oil severely swelled PDMS and deformed the microfluidic device. 
Furthermore, the droplets flowed through the microfluidic device in a strange 
manner due to the affinity differences between the oil and aqueous phase to 
PDMS (Figure 3.4.(b)).  
Finally, isopropyl myristate with 2% w/v DPHS was tested for the droplet 
stability. The droplets showed an excellent stability and no droplet coalescence or  
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Figure 3.4. Droplets flowing through the microfluidic chamber array with different oil 
formulations mixed with 2.0% w/v DPHS. (a) Mineral oil, (b) Isopar M, (c) Isopropyl 
myristate. Scale bar indicates 150 µm. 
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Figure 3.5.  The images of droplets containing iron(III) thiocyanate solution flowing through the 
trapping arrays at the inlet (left) and the outlet (right) of the device.  
droplets showed no visible contrast (Figure 3.4.(c)). In order to show the leakage 
flocculation was observed during the droplet flow through the microfluidic 
chamber arrays (Figure 3.4.(c)). Unfortunately, the oil and the surfactant were 
lipophilic and both fluorescent and non-fluorescent dyes leaked out from the 
aqueous phase to the continuous phase (Figure 3.5). This property made it 
difficult to perform high throughput screening experiments using the 
oil/surfactant mixture. Figure 3.4.(c) shows the flow of the droplets containing an 
ionic dye (iron(III) thiocyanate) by mixing 0.067M Fe(NO)3 and 0.2M KSCN. 
Although the dye was used to visualize the droplets from the continuous oil phase, 
the continuous phase and the of the dye into the continuous phase, the droplet 
images at the inlet and the outlet of the device were compared where the dye 
migration into the continuous phase is clearly observed (Figure 3.5). 
3.2. Fluorinated Di-block Copolymer 
As none of the commercial surfactants showed satisfactory performance for uses 
in droplet based microfluidic high throughput screening applications, a new 
surfactant had to be found. In the literature, the perfluorinated triblock 
copolymer surfactant called Raindance EA surfactant is frequently used for 
droplet based high throughput screening applications (1, 8). The EA surfactant 
consists of perfluorinated polyethers (PFPE), and polyethylene glycol (PEG) 
chains (PFPE-PEG-PFPE) and is an ideal surfactant for performing biological 
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droplet based microfluidic experiments (1). It provides robust droplets with 
minimal droplet coalescence and breakage as well as being both hydrophobic and 
lipophobic (8). The hydrophobicity enables facile generation of droplets while the 
lipophobicity ensures low solubility of the biological reagents in the oil and 
prevents migration of the biological molecules from the aqueuous phase to the oil 
phase as well as preventing the molecular diffusion between neighboring drops 
(7).  In addition they do not swell PDMS and has good solubility for gases which 
allows supply of dissolved oxygen to the droplets directly from the oil phase. Also, 
the surfactant is non-ionic which means that biomolecules do not adsorb to the 
Water/ Oil interface.  
Unfortunately, the surfactant is no longer provided by companies and a similar 
molecule had to be custom synthesized. Recently, a similar perfluorinated 
surfactant was synthesized and used for microfluidic systems by Han and his 
coworkers (9). As the detailed procedure of the chemical synthesis was provided 
by the authors, the surfactant was synthesized and characterized in terms of 
droplet generation, stability, lipophilicity, and cytotoxicity for uses in the 
photosensitiser high throughput screening platform. 
3.2.1. Synthesis 
The biocompatible perfluorinated surfactant was synthesized as described in the 
paper by Chen et al. (9). Krytox 157 (FSH, MW: ~5000 g/mol, Dupont, USA, 100g) 
was degassed under vacuum for a few hours to get rid of any moisture within. 
Then it was dissolved in anhydrous HFE-7100 (Sigma Aldrich, UK, 100 ml) in a 
250ml three necked round bottom flask. The flask was fitted with suba seals 
through which reagents can be delivered whilst keeping the chamber under inert 
argon gas. Then excess oxalyl chloride (Sigma Aldrich, UK, 25 grams) was 
introduced to the mixture slowly. The reaction mixture was then left stirring 
overnight at 85 °C under argon. The solvent was then removed to obtain slightly 
yellow product. The resulting product was mixed with PEG (ED-900, Jeffamine 
XTJ 501, MW: 900g/mol, Sigma, 6.93g) and dissolved in the solvent mixture 
consisting of HFE 7100 (100ml) and  
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Figure 3.6.  Synthesis route for PFPE-PEG-PFPE triblock copolymer surfactant used for 
microdroplet stabilization. 
anhydrous dichloromethane (Sigma Aldrich, UK, 100ml). The reaction mixture 
was heated to 65 °C and left continuously stirring for 2 days under argon to form 
the resulting product with milky colour. After removing the solvents, the product 
was centrifuged at 8000 rpm to remove white particles. The obtained product was 
dried in a vacuum desiccator for a day and used in the experiments without 
further purification. 
3.2.2. Droplet stability 
Microdroplets were generated and their stability was tested using various 
methods. Firstly, the droplets in FC40 with 2 % w/v surfactant were collected 
within a plastic syringe and tested for the droplet coalescence with time (Figure 
3.7). They were shown to be extremely stable against coalescence and virtually 
none of the droplets merged with each other over a period of three weeks. During 
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Figure 3.7.  Microdroplet stability test in FC40 with 2 % of the synthesized surfactant over 3 weeks. 
Scale bar indicates 200 µm. 
the droplet storage, the droplet size decreased due to the evaporation within the 
syringe (Figure 3.7).  
Droplets were also tested using the microfluidic chamber array. This allows one 
to put a wide range of pressure on the droplets by simply varying the total flow 
rate. When 2% of the perfluorinated surfactant was mixed with FC40 and 
HFE7500, no droplet coalescence was observed up to the total flow rate of 30 
µl/min (Figure 3.8). In terms of the droplet stability against droplet breakage 
within the chamber, it appeared that the viscosity of the continuous phase had a 
large effect on it. With higher viscosity, the droplets experience higher shear 
stress within the microfluidic chamber which induces the droplet breakage 
within the chamber. As such, droplets in FC40 oil (Figure 3.8(b)) were more 
prone to droplet breakage than droplets in HFE7500 (Figure 3.8.(a)) as FC40 is 
more viscous than HFE7500. 
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Figure 3.8.  Microdroplet stability test within microfluidic chamber array with 2% of the custom 
synthesized perfluorinated surfactant in HFE7500 (a) and FC40 (b). Scale bar indicates 
150 µm. 
3.2.3. Dye partitioning 
Perfluorinated oils such as FC40 and HFE7500 are both lipophobic and 
hydrophobic. This means that lipophilic dyes do not cross over to the continuous 
phase and enables droplets to be separate vessels for biological reactions. If the 
lipophilic dyes partition into the lipophilic continuous phase such as isopropyl 
myristate, it causes cross-contamination between droplets and can also cause loss 
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of the reactivity of the reagents encapsulated within droplets. In order to test this 
visually, the lipophilic dyes were added into the aqueous phase and the droplets 
were generated and parked in the microfluidic chamber arrays. No leakage of the 
dyes into the continuous phase was observed for FC40 as opposed to lipophilic 
oils such as isopropyl myristate (Figure 3.5). 
3.2.4. Cytotoxicity 
In order to test the biocompatibility of oil/surfactant mixture, E.coli cells were 
kept in droplets for a period of over five days and the effect of the oil on the cell 
viability was assessed using off-chip viability assay staining method (SYTO9-PI). 
As droplets were stabilized by surfactant, the cell containing emulsion was 
broken by resuspending droplets in FC40 oil and centrifuging it at 1000 rpm for 
five minutes prior to viability testing. The cell suspensions were treated with 
 
 
 
 
 
 
 
 
 
 
Figure 3.9.  Cell survival in aqueous droplets in FC-40 containing 1.8 % custom synthesized PEG-
PFPE triblock biocompatible perfluorinated surfactant. The viability of the cells in 
microdroplets remained >80 % over the course of five days. 
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viability assay off chip and introduced into a microfluidic chip for analysis. 
Approximately 20 % of the cells out of the live cell population were scored as dead 
(Fig. 3.9) which is in agreement with many of the previous studies reported on 
the cell viability in microdroplets (10). The cell survival rates were found to be 
consistently over 80 % without any measurable negative effects on the cells (Fig. 
3.9). 
3.3. Microfluidic Droplet Generation 
Droplet generation was investigated for two different droplet generation 
geometries using a Phantom v649 high speed CCD camera (Vision Research, 
USA). As shown in Figure 3.10., droplets were generating using both flow 
focusing and T-junction geometries. In particular, the effects of water fraction, 
flow rates, and viscosity on the droplet formation processes in T-junction 
geometry were analyzed in detail. Various oils and surfactant mixtures were 
employed for investigating droplet formation; 10:1 (v/v) mixture of 
perfluorodecalin (Sigma-Aldrich, UK) and 1H, 1H, 2H, 2H-perfluorooctanol 
(Sigma-Aldrich UK), 1.8% Raindance EA surfactant in FC40 (Acota Ltd, UK) and 
HFE7500 (Acota Ltd, UK), and  4% ABIL EM90 (Surfachem Group Ltd, UK) in 
light mineral oil (Sigma-Aldrich, UK). An iron(III) thiocyanate [Fe(SCN)3] 
solution prepared by mixing 0.067M Fe(NO)3 and 0.2M KSCN was used to 
visualize the microdroplets and obtain the brightness contrast between oil phase 
and aqueous phase. All solutions were pumped into microfluidic devices by 
precision syringe pumps (Harvard Apparatus, UK). 
3.3.1. Droplet generation analysis 
Recorded droplet generation videos were analyzed by using an image processing 
algorithm developed in Matlab written by Soongwon Cho. Droplet generation 
videos were recorded using a high speed camera fitted on an inverted microscope 
(Olympus UK Ltd, UK). In these videos, droplets appear darker than the oil 
phase as aqueous phase contains a dark red coloured iron (III) thiocyanate 
solution. Since the brightness profile of a droplet is different from that of oil  
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Figure. 3.10.  Microfluidic droplet generation devices. (a) Flow focusing droplet generation, (b) T-
junction droplet generation. Scale bars indicate 100 µm. 
phase, brightness contrast analysis of the video gives information on the droplet 
size, monodispersity, inter-droplet spacing, and frequency. First, Image J 
program is used to scan brightness at a fixed scanning point of the image for the 
whole movie using ‘measure stack’ command as shown in Figure 3.11 (a). This 
gives a plot of the brightness at a fixed point of the video over the whole duration 
of the movie and an example of such raw brightness scan plot over 200 frames is 
given in Figure 3.11 (b). In this plot, droplets consistently have lower brightness 
intensities than the oil phase and this allows the digitalization of the brightness 
data. In other words, a brightness threshold value is set to differentiate between 
background (above threshold value) and droplet (below threshold value) 
brightness intensities and the data is then converted to a floating number 
between 0 (below threshold) and 1 (above threshold). The value of 0 corresponds 
to the droplet phase while 1 corresponds to the oil phase. An example of the 
digitalized brightness scan recorded over 3.2 seconds (200 frames) is shown in 
Figure 3.11 (c). Now that droplets and inter-droplet spacing signals are 
differentiated and digitalized, information on various aspects of droplet 
generation process can be obtained such as droplet size distributions, inter-
droplet distance, frequency, and monodispersity. Accordingly,  two key  
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Figure 3.11  Brightness scan with Image j and Matlab. (a) Brightness scan at the detection point for 
the video file. (b) Brightness profile. (c) After image processing with matlab. W 
signifies width of droplets while Td is the distance between droplets. 
 
 
 
 
 
Figure 3.12.  Droplet generation process characterized using the Matlab program. (a) Droplet size 
distribution  (b) Inter-droplet spacing distribution.  
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parameters were defined, and analyzed for each data set; the pulse width (W), 
and the time difference between droplets (Td). Then histograms of the droplet 
pulse widths and the time difference between droplets were plotted as shown in 
Figure 3.12 (a) and (b), respectively. In these plots, information about the 
monodispersity and stability of the droplet generation at a given time frame can 
be obtained. 
3.4. T-junction 
In T-junction geometry, the aqueous phase perpendicularly intersects the main 
channel containing the oil phase (11). The two phases form an interface at the 
junction and the shear forces generated by the oil phase cause the breakup of the 
aqueous phase into droplets. In these configurations, large droplets are typically 
formed and the sizes can be changed by altering the respective flow rates of the 
aqueous and continuous phase, channel widths, and the relative viscosity of the 
two phases. One inlet T-junction device, shown in Figure 3.10, was used for these 
experiments and various oil/surfactant mixtures such as HFE7500, FC40 and 
mineral oil were employed to investigate the droplet generation process. Water 
fractions were varied between 0.1 to 0.5 at total flow rates between 2µl/min and 
8µl/min. 3 minutes interval between each measurement was allowed in order to 
equilibrate the pressure in micro-channels.  
3.4.1. Measured linear flow velocity against prediction 
To verify that the input flow rates of the pump accurately reflects the output flow 
rates, the linear flow velocity of the droplets in microfluidic channel was measured 
and compared with the expected linear flow velocity. Linear flow velocity is 
defined in the equation below.  
Linear flow velocity = Droplet size/droplet pulse widths              (Eq.3.1) 
The linear flow velocity measurements also allow more accurate comparison of the 
droplet formation process between different oil/surfactant mixtures. As can be 
seen from Figure 3.13, measured linear flow velocity is linearly proportional to the  
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Figure 3.13.  Linear droplet flow velocity as a function of the total input flow rates for HFE7500 
based microfluidic droplet generation process. The line indicates a theoretical 
calculation for the linear flow velocity variation with the total flow rate. 
input flow rates and is comparable to the theoretically calculated flow velocity 
(solid line). The theoretical flow velocity can be calculated by dividing the input 
flow rates by the channel dimensions. The slight deviation of the experimental 
measurements from the theoretical values could be due to the syringe pump, 
slight differences in the microfluidic channel dimensions and the back-pressure. 
3.4.2. Effect of Water fraction on droplet sizes 
Water fraction is defined as the volumetric ratios between the oil and the aqueous 
phase. In order to investigate the effect of water fraction on droplet sizes, droplets 
were generated using the T-junction microfluidic device and mineral oil with 4% 
w/v Abil em-90 was used as the continuous oil phase. The length of droplets can be 
controlled by varying the water fraction. Figure 3.14 shows the variation of 
droplet sizes (a) and inter-droplet distance (b) with varying water fraction values 
for mineral oil. By increasing the water fraction at a given total flow rate, the 
aqueous  
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Figure 3.14.  (a) Droplet size variation with water fraction at various total flow rates. (b) Inter-
droplet spacing variation with water fraction at various total flow rates.  
 
 
(a) 
(b) 
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flow rate increases while the oil flow rate decreases. Thus the aqueous flow rate is 
faster and the continuous oil flow rate is slower at the droplet generation junction 
which means that the shear force exerted on the aqueous flow is lower. Therefore, 
the size of the droplet increases with increasing water fraction while the inter-
droplet spacing decreases with water fraction. The parabolic dependence of the 
droplet spacing on water fraction has also been reported in previous studies by 
Tice et al. (12) and is in agreement with the results presented here. 
3.4.3. Effect of total flow rate on droplet sizes 
While the droplet sizes have clear dependence on the water fraction values, the 
relationship between total flow rate and water fraction is less clear (Figure 
3.14.(b)). The surface tension at the liquid-liquid interface and the relative 
viscosity of fluids play important roles in droplet generation processes (12). As the 
surface tension allows the interface to resist the viscous force, the droplet sizes are 
dependent on the ratio of the viscous force and surface tension. Thus, the droplet 
generation process is governed by the capillary number which gives the relative 
effect of viscous forces versus surface tension acting across an interface between 
water and oil. The capillary number is a dimensionless parameter and is given by 
eq. 3.2. 
Ca = Uµ/Ƴ                                 (Eq. 3.2) 
where U (ms-1) is the total linear flow velocity, Ƴ  (N m-1) is the surface tension at 
the liquid-liquid interface and µ (kgm-1s-1) is the viscosity of the fluid. As the 
viscosity of the mineral oil is 7.32 times higher than that of FC-40, the capillary 
number is much higher for mineral oil at the same flow rate. Using equation 3.2, 
the capillary numbers of mineral oil, FC-40, and HFE7500 at 0.001 m/sec flow 
velocity were calculated to be 7.0 X 10-6, 8.2 X 10-7, and 1.7 X 10-7 respectively. As 
can be seen from Figure 3.15 (a), the droplet size decrease with increasing total 
flow rate for mineral oil mixed with 2% ABIL em90. On the other hand, the 
droplet size shows no dependence on the total flow rate for the same total flow rate 
range for FC 40 with 1.8% EA surfactant (Fig. 3.15.(b)). This is in excellent 
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Figure 3.15.  Droplet size variation with water fraction at various total flow rates for (a) mineral oil 
and (b) FC-40.  
 
(a) 
(b) 
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agreement with findings that the droplet sizes are dependent on the flow velocity 
at high capillary number while they are only weakly dependent on the flow 
velocity at low capillary number (12, 13). Droplets were generated at higher flow 
velocity using FC40 oil mixture in order to find out whether this is because of the 
differences in the capillary number. As Figure 3.17 shows, the droplet sizes 
created using FC40 oil also showed a linear dependence on the inverse of the flow 
velocity at high capillary number.  
3.4.4. Effect of Viscosity on droplet generation 
The relative viscosities of the fluids also have significant effects on the droplet 
generation processes. Higher continuous phase viscosity means that greater 
viscous forces are going to be applied to the liquid-liquid interface during droplet 
generation leading to smaller droplets being formed. The size variation of droplets 
as a function of the ratio of water flow rate to oil flow rate and the oil viscosity was 
investigated as shown in figure 3.17. Droplet diameter ranged from 200 µm for 
mineral oil to 600 µm for HFE7500. As the water fraction rises, the droplet size 
also increases for all three types of oils tested. The viscosities of mineral oil, FC40  
 
 
 
 
 
 
 
 
Figure 3.16.  Droplet size variation with water fraction for different oils with varying viscosity.   
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and HFE7500 are 0.03, 0.0041 and 0.00112 Pa s, respectively. As can be seen from 
Figure 3.16, oils with higher viscosity consistently produced smaller sized droplets 
at all water fraction values. 
3.4.5. Droplet Frequency analysis 
Droplet frequency variation with the total flow rate and water fraction was also 
investigated. Controlling droplet frequency and spacing is vital for droplet based 
microfluidic applications with complicated reaction schemes requiring precise 
control of droplet sizes and frequency in order to achieve controlled coalescence of 
droplets. As droplet frequency is a function of the aqueous flow rate, and 
individual droplet volumes, it can be controlled by changing the total flow rate and 
water fraction. At a given aqueous flow rate, smaller droplets give rise to higher 
droplet frequency. In Figure 3.17, the variation of the droplet generation 
frequency with water fraction and total flow rate is shown. As discussed 
previously, increasing total flow rate has relatively small effects on the droplet 
size at low capillary number and at higher capillary number the droplet diameter 
is inversely proportional to the total flow rate. This means that higher droplet 
frequency can be readily obtained by simply increasing the total flow rate. In fact, 
at a given water fraction, the droplet frequency was linearly proportional to the 
total flow rate. On the other hand, the water fraction has relatively little effect on 
the droplet frequency. Only slight increase in the droplet frequency was observed 
with increasing water fraction.  
3.4.6. Droplet generation instabilities 
Droplet generation was reproducible for water fractions between 0.3 and 0.5. At 
higher water fractions above 0.6, laminar flow problems led to large fluctuations 
in droplet sizes. At lower water fractions below 0.3, the aqueous phase was often 
pushed back by the oil phase leading to unstable droplet generation. It should also 
be noted that at low flow rates, droplet generation was also unstable due to 
inherent fluctuations in the back-pressure. Inconsistencies of droplet sizes at slow 
pumping rate below 0.3 µlmin-1 were observed due to instabilities in pumping. 
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This is caused by the slightly irregular motion of the syringe pumps at low flow 
rates. Also droplet formation was less stable at both high and low water fractions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17.  Droplet generation frequency analysis. (a) Droplet generation frequency variation with 
total flow rate. (b) Droplet frequency variation with water fraction. 
 
(b) 
(a) 
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3.5. Summary 
Various types of surfactants were tested for the suitability for the biological 
droplet based microfluidic platform.  Various properties of the surfactants were 
obtained such as droplet stability against merging and breakage, biocompatibility, 
and lipophilicity. A robust perfluorinated triblock copolymer surfactant was 
synthesized and found to have excellent properties for uses within microdroplet 
applications. Then, droplet generation process was investigated in depth. Effects 
of the viscosity, flow rate and water fraction on the droplet sizes were elucidated. 
The understanding of the droplet generation would be useful for the droplet 
synchronization and handling when performing complex microdroplet operations. 
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Chapter 4. Microfluidic Module Development  
This chapter presents the development of a modular droplet-based microfluidic 
platform for performing high throughput cytotoxicity screening of 
photosensitizers against microbial organisms. The screening platform consists of 
four major microfluidic modules; a) a droplet generation module for cells and 
photosensitisers, b) a microfluidic droplet incubation module capable of dark 
incubation, on-chip light exposure, and droplet reinjection c) an 
electrocoalescence module for merging cell containing droplets with those 
containing viability assay, and d) an incubation channel for cell viability 
detection. In order to perform these functions, multiple novel fluidic operation 
modalities such as large-scale microfluidic chamber for light irradiation, 
reinjection module and low voltage driven electrocoalescence were developed and 
integrated within a microfluidic platform for photosensitiser screening.  
4.1. Proposed microfluidic screening workflow 
For a typical bulk photosensitiser screening experiments, the screening workflow 
consists of the following steps; (a) dark incubation of cells in presence of 
photosensitisers allowing penetration of photosensitisers into cells, (b) light 
irradiation of samples and (c) cell viability detection.  
A microfluidic screening platform must be able to perform these steps reliably 
with sufficient control and throughput. A simple schematic representation of the 
intended microfluidic experimental design is shown in figure 4.1. Briefly, cells and 
photosensitiser are mixed, formed into droplets, and incubated together under 
dark in order to allow the photosensitiser penetration into cells. After light 
exposure of these droplets, the viability assay reagents are introduced and 
incubated in order to label dead and live cells. Then the signals from cells are 
detected using an on-line microfluidic detection channel for viability scoring.  
In order to perform the screening workflow within a microfluidic platform, it is 
essential to develop noble microfluidic modules capable of several functions.  
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Figure 4.1.  Microfluidic photosensitiser screening platform outline. Cells and photosensitisers are 
mixed into aqueous droplets, incubated in dark to allow penetration of photosensitisers, 
exposed to light, merged with viability assay containing droplets and incubated within 
microfluidic device for viability scoring. 
Firstly, it is necessary to generate stable droplets containing cells and 
photosensitisers that do not merge or break during highly pressurized situations. 
In order to achieve this, a perfluorinated biocompatible block-copolymer 
surfactant was synthesized. Secondly, a microfluidic incubation module must be 
capable of incubating droplets for hours whilst allowing for reliable light 
exposure and oxygen delivery. After light exposure, a viability assay reagent 
needs to be introduced to the photosensitised cells and incubated for 20-30 
minutes in order to identify the dead and live cells. Finally, the microfluidic 
platform must be able to perform all of these functions reliably whilst allowing 
for screening various parameters such as photosensitiser concentrations, light 
doses, oxygen concentrations, reaction time and dark toxicity.  
In this chapter, the development of each of these microfluidic modules will be 
discussed and the proof-of-concept microfluidic platform combining all the 
individual modules will be presented. 
4.2. Droplet Generation for Cells and Photosensitiser 
Droplets containing E.coli cells and photosensitisers were generated using a 60 µm 
deep two-inlet T-junction nozzle (Fig. 4.2.). FC-40 oil with the custom synthesized 
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perfluorinated biocompatible surfactant was used as the carrier phase while E.coli 
cells (A600nm = 0.25) and photosensitiser (TBO) were introduced from two aqueous 
inlets (Fig. 4.2.(c)). As the cell suspension caused wetting of the device due to 
increased lipophilicity (Fig 4.2.(a)), the droplet generation microfluidic device was 
flushed with 1 % v/v trichloro(1,1,2,2,-perfluorooctyl)silane (Sigma- Aldrich Ltd., 
UK) in FC-40 in order to render the channel hydrophobic. After hydrophobic 
treatment, stable droplet formation was achieved as shown in Figure 4.2.(b). All 
solutions were filtered using 0.2 µm sterile filter (Pall Corp., USA) before use in 
order to reduce device failure due to large particles during droplet generation. 
Various flow rates and water fraction were successfully tested for stable droplet 
generation. For the actual microfluidic screening experiment, both aqueous 
solutions were pumped into the microfluidic device using flow rates of 5 µl min-1 
while the oil phase was pumped at a flow rate of 10 µl min-1 resulting in 
generation of 140 pL droplets at a frequency of 650 Hz. High frequency droplet 
generation was particularly important for reducing dark incubation time 
dispersion when a microfluidic chamber was used for light exposure. 
4.3. Dark Incubation and Light exposure Module 
Having successfully generated microdroplets containing cells and photosensitiser, 
the droplets need to be incubated in dark and under light in order to assess the 
effects of the photosensitiser on the cells. The timescale of each screening steps is 
one of the most critical factors for designing a droplet based microfluidic high-
throughput screening platform. Typical timescales for bacterial cell based 
photosensitiser screening experiments are as follows; from 20 minutes up to 4 
hours for the dark incubation step (1), 30 minutes to a few hours for light 
irradiation (2) As these conditions depend on many factors such as the type of the 
cell line, photosensitisers, light source, and viability detection method, a 
microfluidic platform must be able to screen for a wide range of experimental 
conditions in a flexible manner without device failures. In particular, the 
incubation module must be able to incubate droplets for a wide range of 
incubation time as dark incubation and light irradiation steps can take any time  
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Figure 4.2.  A T-junction microfluidic geometry for generating droplets containing cells and 
photosensitisers. (a) Wetting of the T-junction device, (b) Stable droplet generation 
after hydrophobic treatment. Scale bar indicates 60 µm.  (c)  E.coli cells and 
photosensitiser encapsulated within droplets. Scale bar: 3 µm. 
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Figure 4.3.  Examples of continuous flow based microfluidic incubators. (a) Plug based 
microfluidic incubation line (b) Wide microfluidic delay line. Scale bars indicate 50 
µm. 
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between a few minutes to a day depending on the experimental conditions. 
Thus it was necessary to develop a reliable droplet incubation line capable of 
incubating droplets over a few hours whilst allowing for uniform light exposure. 
In fact, the development of a reliable droplet incubation line is one of the key 
issues in droplet based microfluidics for high throughput screening applications.  
There are currently two types of droplet based microfluidic incubators; 
continuous flow based microfluidic incubators (3, 4) and stop-flow incubators (5, 
6). In continuous flow based microfluidic incubators, the droplets are incubated 
by flowing them through a microfluidic delay line. For reactions requiring short 
incubation time, droplets flow through a narrow microfluidic channel as a single 
file to obtain constant incubation time for all droplets as shown in Figure 4.3.(a). 
Although this approach allows exact control of the droplet residence time in 
microfluidic channels, droplet flow within narrow microfluidic channel induces 
large back-pressure as pressure is inversely proportional to the dimensions of the 
micro channel. Several problems can arise from large hydrodynamic 
backpressure such as device delamination, expansion of pdms devices, and device 
to tubing interconnection failures.  
Pressures can be estimated from Poiseuille’s law as shown below: 
 P 
128 LQ
 d4
       (Eq. 4.1.) 
where  P is the pressure drop, µ is the dynamic viscosity, L is the length of the 
channel, Q is the volumetric flow rate and d is the diameter of micro-tube. 
Therefore, a wide channel (Fig. 4.3.(b)) is used to reduce the hydrodynamic 
resistance while increasing reaction time. Furthermore, the depth of the 
microfluidic channel can be increased in order to reduce the pressure drop.  
Unfortunately, the wide microfluidic delay line suffers from large droplet 
incubation time dispersion due to the nonuniform velocity profile in a wide micro 
channel.  
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Figure 4.4.  Examples of stop flow based droplet incubators. (a) Chamber based microfluidic 
droplet incubator (b) Off-chip microdroplet Incubator. Scale bars indicate 1 mm. 
In addition, they still suffer from relatively large back pressure and the longest 
continuous flow delay line to date is 69 minutes reported by Griffiths and his co-
workers (3). As the minimum incubation time of 60 minutes is required for the 
photosensitiser screening, the continuous flow based incubation line is inefficient, 
time consuming and prone to device failures for dark incubation and light 
exposure purposes.  
On the other hand, a stop-flow droplet incubator is often used for reactions 
requiring a long incubation time. Essentially, these stop flow incubators are able 
to collect, incubate and reinject droplets into another microfluidic device for 
further processing. Various types of microdroplet incubators exist such as a long 
tubing (7), an external droplet collector (4) and a large microfluidic chamber (6). 
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By stopping the flow, large number of droplets can be incubated for a long time. 
These droplets can be further processed by reinjecting them into another 
microfluidic device.  
Off-chip microdroplet collection device is often used for reactions requiring long 
incubation periods (4). A custom fabricated microdroplet collection device was 
tested for droplet storage and reinjection (Figure 4.4.(b)). After microfluidic 
droplet formation, droplets were immediately collected via 0.38 mm inner 
diameter PTFE tubing (Smiths Medical UK, UK) into a custom fabricated droplet 
collection module shown in Figure 4.4.(b). The droplet collection module composes 
of a 1ml BD Plastipak Syringe (BD Plastics Ltd, USA) body with internal 
diameter of 4.68 mm, a 25G BD microlance needle (BD Plastics Ltd, USA), and 
an interconnection part composing of a syringe needle, a PTFE tubing and room 
temperature curing epoxy (Micro Measurement, USA). This collection module 
was connected to the microfluidic device on one side and a syringe containing FC-
40 oil with 1.8% custom synthesized PEG-triblock biocompatible fluorinated 
surfactant on the other side. This syringe was used to collect and reinject droplets 
by perfusing and refilling process. As expansion and compression of air bubbles 
can cause large fluctuations in the exerted pressure during the device operation, 
the air bubbles were carefully removed from the assembled collection device prior 
to droplet collection. Collected droplets can be incubated and remain stable 
within the device with minimal coalescence for more than 3 weeks. Because the 
FC-40 density (1855kg/m3) is higher than that of water (1000kg/m3), aqueous 
droplets float on the top and remain closely packed within the collection device so 
that they can be reinjected into another device in an orderly fashion. 
Unfortunately, these devices were not suitable for light exposure purpose in 
droplet based microfluidic photosensitiser screening workflow as the uniform 
exposure of all droplets was difficult to achieve.   
Recently, a microfluidic chamber was used to perform simultaneous on-chip 
polymerase chain reaction amplification of over 1-million monodisperse droplets 
(6). These microfluidic chamber devices are planar and allow over a million 
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microdroplets to be stored within the chamber for a long time with minimal 
droplet coalescence (Figure 4.4.(a)). As droplets are stored in a narrow planar 
space, light can be delivered reliably to the droplets within the chamber. As such, 
the chamber based microfluidic structure was investigated for light exposure 
purposes within the microfluidic photosensitiser screening workflow. 
4.3.1. Microfluidic chamber and device operations 
Prototype microfluidic chamber devices were fabricated out of PDMS and tested 
for collection, storage and reinjection of microdroplets (Figure 4.5(a)). Briefly, the 
device consists of a droplet generation part, a large chamber capable of storing 
millions of droplets, pillar arrays for keeping droplets within the chamber, and an 
oil inlet which allows pushing droplets out of the device. The device was 
fabricated using PDMS as it allows fast prototyping and integration of different 
functionalities within the device such as droplet generation structure, and pillar 
arrays. Microdroplets were successfully collected and stored within these devices 
as shown in Figure 4.5.  
By integrating a set of pillar arrays within the device, it was possible to fill up 
the device with droplets without losing them at the outlet. In addition, the pillars 
acted as a filter for any air bubbles from the flow driving syringe during the 
device operation which allows facile reinjection of droplets from the chamber into 
another microfluidic device. Unfortunately PDMS is an elastic material and has 
low Young’s Modulus value of ~4 MPa (8). As the device suffers from large 
pressure during the droplet reinjection into another microfluidic device, the 
device is prone to many potential failures such as device delamination, expansion, 
and leakage at the chip/tubing interface. In particular, the expansion of the 
device due to back-pressure during reinjection process was a major problem 
because even a slight expansion of the chamber can result in droplets being 
reinjected irregularly to the other device. In fact, the elasticity of the PDMS 
material was such that it was impossible to reinject the droplets from the 
chamber into the viability scoring device consisting of droplet reinjection nozzle  
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Figure 4.5.  (a) First generation PDMS based microfluidic chamber. Scale bar indicates 100 µm. (b) 
TPE based microfluidic chamber. Scale bar indicates 0.5 mm (c) Steel connection for 
interfacing the syringe/reinjection device to the microfluidic chamber. Scale bar 
indicates 0.3 mm. 
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and spacer oil for droplet electrocoalescence. Changes in the chamber size, PDMS 
catalyst ratio and introduction of support pillars did not prevent the chamber 
expansion sufficiently to allow facile reinjection of droplets.  
In order to avoid the device failures due to the expansion of the chamber, 
thermoset polyester material (TPE) was employed for fabricating the chamber. 
TPE microfluidic devices were fabricated using soft lithography which allows 
rapid prototyping of microfluidic devices by using PDMS microstructures as the 
moulds. Furthermore, TPE is a hard plastic material with Young’s modulus of 3.8 
GPa which prevents the expansion of the device material during the operation of 
the device. Furthermore a pillar (0.5 mm x 0.5 mm) was placed at the centre of 
the chamber as shown in Figure 4.5.(b). The pillar (0.5 mm X 0.5 mm) holds the 
top and the bottom part of the device together which limits the expansion of the 
microfluidic chamber. The depth of the chamber was 200 µm which allows the 
droplet storage capacity of over millions of droplets. In these devices, it was 
difficult to integrate small sized droplet generation module and micro-pillars due 
to TPE device fabrication limitations and separate PDMS devices were used for 
droplet generation as described in section 4.2.  
The fully assembled microfluidic chamber device consists of a thermoset polyester 
based microfluidic chamber, two pieces of PTFE tubing inserted into the device 
for interfacing, and epoxy which seals the interface between the microfluidic 
device and the PTFE tubings (Figure 4.5.(b)). A strong interconnection between 
the microfluidic chamber and PTFE tubing was achieved by exposing the tubing 
to the plasma in order to strengthen the bonding between the tubing and the 
epoxy glue by increasing the hydrophilicity of the tubing surface. This prevents 
fluids from leaking out through the interface between the microfluidic chamber 
and PTFE tubings. The tubings were connected to other microfluidic devices and 
the driving syringe by using a custom made steel connection as shown in Figure 
4.5.(c). When gas impermeability was required for the screening experiments, a 
combination of PEEK tubing (Sigma-Aldrich, UK), PEEK union (Sigma-Aldrich, 
UK) and steel connection were used. 
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The operation of the microfluidic chamber is as follows. Firstly, the microfluidic 
chamber and the tubings were completely filled with FC-40 with 1.8% EA’ 
surfactant to coat the surfaces. Sufficient coating of all the tubings and devices 
with the continuous phase was one of the key steps in achieving reliable 
collection of droplets. When the surfaces were not preconditioned with the oil and 
surfactant mixture, the hydrophilic nature of the devices and tubings caused 
unwanted coalescences of droplets.  
Secondly, pregenerated droplets containing cells and photosensitisers were 
loaded into the microfluidic chamber and incubated under dark. These droplets 
were not generated simultaneously and this resulted in large dispersion of the 
incubation time. This can be avoided by generating droplets using very high flow 
rates (20 - 60 µl/min) which allow the whole chamber device to be filled with 
droplets within 10 minutes, reducing the droplet incubation time dispersion. 
Since dark incubation time was 1 hour for microfluidic photosensitiser screening 
experiments, this was found to have small effects on the cell viability. After light  
 
 
 
 
 
 
 
 
 
Figure 4.6.  Optical transmittance of 1mm TPE strip, 1mm PDMS strip, and 1mm Glass slide. 
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Figure 4.7.  Toluidine Blue O Absorption spectrum in DI water. 
exposure, the device was then connected to a syringe containing FC-40 with 
surfactant at one end and another microfluidic device at the other end. When the 
chamber was placed so that the device outlet leading to the next microfluidic 
device was facing up, droplets floated towards the outlet on top of the oil layer 
and remained closely-packed. Close-packed droplets can then be reinjected with 
regular droplet frequency and spacing. Thus, it was possible to reinject droplets 
into another device in a regular fashion for further processing by simply pushing 
with oil from the bottom of the device.  
4.3.2. Thermoset Polyester Transmission spectrum and light source 
In this section, the suitability of TPE as the device material for microfluidic 
photosensitiser screening light exposure platform was assessed in terms of its 
optical properties. Optical transparency is an important property for TPE based 
microfluidic chamber structure for light exposure purposes as light dosage is an 
important parameter for photodynamic therapy as the cell viability is heavily 
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influenced by light dosage. The optical transmittance values of 1mm thick PDMS, 
TPE, and glass samples were measured between 200 nm to 800 nm as shown in 
Figure 4.6. For all three samples, the transmittance was over 80% between 400 
and 800 nm with the transmittance of TPE decreasing sharply below 400nm 
compared to glass and PDMS (Fig. 4.6). This, however, does not affect the 
photosensitiser screening process because typically photosensitiser has the 
absorption wavelength range between 650 nm to 800 nm where the absorbance of 
the human tissue is the lowest (9). Also, the spectrum of Toluidine Blue O (TBO) 
in deionized water is shown in Fig 4.7. TBO is the photosensitiser investigated 
for the microfluidic photosensitiser screening here. As TPE has over 90% 
transmittance over the TBO absorbance wavelength range, TPE has suitable 
optical transmittance characteristics for fabricating microfluidic chamber for 
light exposure purposes for the photodynamic inactivation of cells using TBO. 
Transmission light source, TH4-200 (Olympus Medical, UK), was used for  
 
 
 
 
 
 
 
 
 
 
Table 4.1.  The light intensity of the transmission light (Olympus TH-4 200). 
 
89 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8.  Microfluidic chamber under light exposure. Scale bar indicates 1cm. 
screening photosensitisers. TH4-200 has sufficiently strong light power from 500 
nm to 700 nm for TBO photosensitisation and allows the uniform exposure of the 
microfluidic chamber (Fig. 4.8.(b)). It is also a white light source which allows one 
to screen for various types of photosensitisers with different wavelengths if 
necessary. A table of transmission light intensity and a picture of the microfluidic 
device under illumination are shown in Table 4.1 and Figure 4.8, respectively. 
4.3.3. Microfluidic Chamber cytotoxicity 
In order to test the cytotoxic effects of TPE material on cells, the cell viability of 
E.coli cells was assessed after incubating cells within the TPE microfluidic 
chamber. Top10 E.coli strain was used for the experiment. E.coli cells were grown 
in Luria Bertani broth at 37 °C at a shaking incubator at 200 rpm for 16 hours. 
After centrifuging the cell suspension at 1500 rpm for 10 minutes, the 
supernatant was discarded and the remaining cell pellet was resuspended in 
phosphate buffered saline (PBS) so that the optical density at 600 nm was 1.15. 
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Then the cell suspension was injected into the microfluidic chamber and 
incubated at room temperature. Periodically, E.coli cells were taken out from the 
microfluidic chamber and the cell viability was detected by staining the E.coli 
cells with 10 µM SYTO9, 4 µM Propidium Iodide and 4 nM Alexa Fluor 488. Cells 
were incubated for five minutes in presence of the viability assay before injecting 
the cell suspension into microfluidic device for viability scoring. Cells remained 
almost fully viable within the TPE microfluidic device for days with the viability 
of the cells remaining above 80% for over four days with a slight drop of the 
overall viability after a day of incubation. Since cells are only incubated up to a 
few hours in the microfluidic device for the photosensitiser screening experiments, 
the TPE device would not have a large effect on the cell viability during the 
screening process. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9.  TPE cytotoxicity on E.coli cells. 
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4.4. Microfluidic Viability Assay Scoring Device 
After the light exposure of the droplets, viability assay needs to be introduced to 
the droplet and incubated for 30 minutes in order to perform viability scoring. To 
achieve this, the viability scoring device must consist of the following modules.  
(i) Reinjection of the photosensitised, cell-containing droplets into the 
microfluidic viability scoring device via a reinjection nozzle in order to merge 
with fluorescent viability assay containing droplets.  
(ii) Coalescence of droplets with cell suspensions with those containing viability 
assay dyes. The droplet coalescence module must be able to perform this with 
sufficient throughput whilst allowing for a one-to-one droplet fusion. 
 (iii) Incubation of the fused droplets in a delay line with large channel cross-
section allowing the assay reaction to fully develop on-chip.  
(iv) Sensitive microfluidic confocal fluorescence detection for viability scoring. 
Two avalanche photodiode detectors coupled with a 488 nm laser excitation 
source were used to analyse the fluorescence traces from droplets. This system is 
capable of resolving single fluorophore events at frequencies in excess of 50 kHz 
(10). Multilayer lithography was used to manufacture microfluidic channels with 
different thicknesses within a single microfluidic device in order to integrate deep 
incubation channel and shallow fluorescence detection channel (4). 
In the subsequent sections, the development of microfluidic modules will be 
discussed. 
4.4.1. Droplet reinjection 
Droplet reinjection is necessary when the droplets produced in a previous module 
must be reinjected into a microfluidic device for further processing. The 
microfluidic photosensitiser screening platform requires integration of multiple 
microfluidic modules with different functions; droplet generator, incubation 
module for dark incubation and light irradiation, and cell viability scoring 
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module. As droplets need to be incubated for a few hours within the microfluidic 
platform, it is difficult to integrate all the modules within a single microfluidic 
device. Therefore, it is necessary to reinject droplets reliably from the previous 
screening step to the next microfluidic device without unwanted breakage and 
coalescence of droplets. 
 Uniform droplet reinjection from the light irradiation module to the cell viability 
scoring device is particularly important as viability assay needs to be added to 
the droplets in order to perform the viability scoring. The assay cannot be added 
at the previous steps due to the following reasons. 1. Light irradiation step would 
adversely affect the viability assay performance due to photo-bleaching. 2. 
Viability assay incubation time needs to be controlled precisely in order to screen 
for the cell viability. 
 As viability assay needs to be added to the droplets containing photosensitised 
cells, droplets need to be reinjected into the viability scoring device in a uniform 
fashion allowing synchronization with another droplet stream containing the 
viability assay mixture. In order to achieve this, droplets were packed closely 
together by removing most of the continuous phase (FC40) from the emulsion 
mixture. This was achieved by first collecting droplets in a droplet storage device 
such as a syringe or a microfluidic chamber. As the density of water (1.0 g ml-1) is 
lower than that of FC40 (1.87 g ml-1), it is possible to pack droplets tightly by 
simply letting the droplets float towards the outlet of the droplet storage device. 
Syringe pumps were used to control the fluid flow so that droplets can be 
collected and reinjected by infusing and refilling the syringe connected to the 
droplet storage device.  Close packed droplets form hexagonal structures within 
microfluidic channels. When these droplets are reinjected into a microfluidic 
device, the contact forces between the droplets cause them to order and flow 
through the device regularly. These droplets can be re-spaced evenly by 
introducing oil flow as shown in Fig 4.10. During reinjection, the droplets are 
under large pressure which causes them to merge or break at the reinjection 
nozzle of the device. This can be reduced by using less viscous oil and a 
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Figure 4.10.  Droplet reinjection nozzles. (a) First generation non-close packed droplet reinjection 
nozzle. (b) Second generation droplet reinjection nozzle. (c) Third generation 
reinjection nozzle. Scale bars indicate 50 µm. 
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perfluorinated surfactant which stabilizes the interface between droplets.  
Figure 4.10.(a) shows the first generation droplet reinjection nozzle. In this 
design, the droplets were not closely packed together as they were reinjected from 
a syringe horizontally placed on a syringe pump. Therefore, the droplet 
reinjection frequency and inter-droplet spacing could not be controlled reliably. In 
addition, the inlet punch was larger than the designed microfluidic inlet 
structure and droplets suffered from uncontrolled coalescence and breakup due to 
the rugged edges at the reinjection inlet of the device. The rugged edges of the 
inlet hole resulted from the hole punching process. In addition, droplets were 
tightly trapped within the inlet because of the ruggedness which also caused 
large stress on the reinjected droplets. 
Figure 4.10.(b) shows an improved microfluidic inlet design and reliable droplet 
reinjection process. In this attempt, the droplets were closely packed together by 
utilizing the density difference between water and oil. This allowed controlled 
reinjection of droplets at a desired frequency with uniform inter-droplet spacing. 
Also, by using a larger droplet reinjection inlet design, droplet stability at the 
inlet of the device was improved. The ruggedness of the inlet hole shape was 
reduced by using a new hole punch. The reinjected droplets were then evenly 
spaced out by using the spacer oil (FC40) injected perpendicularly at the either 
sides of the droplet reinjection nozzle. This approach allowed stable droplet 
reinjection and the design was further improved to reduce the pressure on the 
incoming droplets by tilting the angle of the spacer oil as shown in Figure 4.10.(c). 
The new design also forces the droplets to form plugs after the introduction of 
continuous phase which is advantageous for maintaining uniform spacing 
between neighboring droplets. In both 4.10.(b) and (c), droplets were reinjected 
evenly with minimal unwanted droplet coalescence. The frequency of the 
reinjected droplets was controlled by changing the droplet reinjection flow rate.  
4.4.2. Droplet reinjection analysis 
Droplet reinjection module was first tested using the syringe based droplet  
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Figure 4.11. (a) Pictures of droplet reinjection at various droplet fraction values. (b) Reinjected 
droplet size variations with droplet fraction for various total flow rates from 1 µl/min to 
5 µl/min. 
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reinjection device (Fig. 4.4.(b)). In order to test the droplet reinjection efficiency, 
the droplet size was assessed both visually and analytically. Figure 4.11.(a) 
shows the photographs of microdroplet reinjection at various droplet fractions 
(Droplet fraction = droplet reinjection flow rate/total flow rate). As can be seen 
from the picture, the droplet sizes were consistent for various droplet fraction 
values as expected and minimal droplet coalescence and breakage were observed. 
The droplet size uniformity was further analyzed at various flow rates and 
droplet fraction values using an in-house Matlab program described in Section 
3.1.1 which analyzes the time it takes for a droplet to pass through a point in a 
video.  
Droplet size is linearly proportional to the time it takes for a droplet to pass 
through a point in a video and the information can be obtained by utilizing the 
brightness difference between the droplets and the continuous phase within the 
microfluidic channel. Given that the droplet sizes, channel geometry and total 
flow velocity are the same, droplets are expected to take the same amount of time 
to pass through a point in a microfluidic channel. In order to analyze the size 
variations of the reinjected droplets, the brightness scanning point was set right 
after the reinjected droplets got spaced out by continuous oil phase. Figure 
4.11.(b) shows that the droplet sizes are consistent over different water fraction 
values with small droplet size distributions (±10%) which demonstrates the 
reliability of the droplet reinjection system.  
Having demonstrated that the reinjected droplet sizes were consistent at various 
different total flow rates and droplet fractions, droplet reinjection frequency was 
investigated and quantified over various droplet reinjection flow rates and oil 
flow rates. Considering that the droplet sizes are the same, linear increase of 
droplet reinjection frequency with the reinjection flow rate is expected. At a given 
total flow rate, droplet reinjection frequency is also expected to have linear 
relationship with droplet fraction. Figure 4.12.(a) shows that droplet reinjection 
frequency is linearly proportional to the total flow rate at a given droplet fraction 
as expected. When the same data set was presented so that the droplet  
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Figure 4.12. (a) Droplet reinjection frequency variation with respect to the total flow rate at various 
droplet fraction values. (b) Droplet reinjection frequency variation with droplet 
reinjection flow rate. 
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reinjection frequency was plotted over the droplet reinjection flow rate, a linear 
dependency of the frequency over the flow rate was observed as expected (Figure 
4.12.(b)). As the average droplet sizes were around 300 pL, 55 droplets/second 
were expected to be reinjected for 1 µl/min reinjection flow rate. As the gradient 
of the fitted line is 52.26, the data shows good agreement with the theoretical 
calculations (Fig. 4.12.(b)). This indicates that the droplet reinjection module 
performance is reliable and the droplet reinjection frequency can be controlled 
simply by changing the droplet reinjection flow rate.  
4.4.3. Chamber based droplet reinjection 
Having successfully tested the reinjection performance of the off-chip droplet 
storage device, the chamber based droplet reinjection was then assessed for 
reliable droplet reinjection. The droplet reinjection process was assessed in a 
reinjection nozzle with improved geometry with the continuous spacer phase 
being introduced more horizontally to the droplet reinjection nozzle so that the 
incoming droplets experience less pressure. In addition, a narrower microfluidic 
channel was used after the droplet spacing by the continuous phase so that the 
droplets flowed through the microfluidic channel as plugs. This ensures the 
preservation of the inter-droplet spacing. During the reinjection of droplets, no 
significant expansion of the TPE microfluidic chamber was observed. Figure 
4.13.(b) and (c) show the linear relationship between the microfluidic chamber 
based reinjection frequency with the total flow rate and the droplet reinjection 
flow rate, respectively. This further indicates that the microfluidic chamber is 
suitable for reinjection and the droplet reinjection frequency can be controlled 
simply by changing the droplet reinjection flow rate.  
4.4.4. Synchronization of droplets and electrofusion 
In order to achieve one-to-one fusion, the reinjected photosensitised cell 
containing droplets must remain evenly spaced in order to allow controlled 
coalescence of droplets. Also, the reinjection frequency needs to be synchronized 
with the droplet generation frequency of droplets containing fluorescent viability 
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Figure 4.13. (a) Microfluidic Chamber based droplet reinjection. Scale bar indicates 50 µm. (b) 
Droplet reinjection frequency variation with the total flow rates for the microfluidic 
chamber. (c) Chamber based reinjection frequency variation with the reinjection flow 
rates.  
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Figure 4.14.  Droplet generation frequency variation with the total flow rate at various water fraction. 
assay dyes. To this end, the droplet reinjection frequency was scaled with the 
droplet reinjection flow rate as shown in Figure 4.13.(c) and droplet generation 
frequency was investigated as a function of total flow rate and water fraction. 
While the reinjection frequency scaled linearly with the reinjection flow rate, the 
droplet generation frequency had a more complicated relationship with aqueous 
flow rate and continuous phase flow rate as droplet sizes varied with the water 
fraction values (Figure 4.14). At a given water fraction value, droplet frequency 
was proportional to the total flow rate for the flow rates investigated. Because the 
size of the droplets was affected largely by water fraction, the dependence of the 
droplet frequency on water fraction value was less clear and had more 
complicated relationship depending on the types of the droplet generator and the 
total flow rate used. Around 30 droplets per second were generated at a total flow 
rate of 3 µl/min using the droplet generation module in the viability scoring 
microfluidic device. During the screening experiments, the droplet reinjection 
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flow rate had to be fine-tuned using the calibrated experimental values to achieve 
one-to-one fusion of droplets. 
Various methods of droplet fusion were reported in the literature using either 
passive techniques(11) or optical(12) or electrical means(13). Electrocoalescence 
is an active technique used to destabilize emulsions and cause their fusion under 
the application of an AC electric field. Using this technique, a droplet fusion rate 
of up to 1 kHz was demonstrated (14). As the droplets are stabilized by a 
surfactant, micro-patterned electrodes were used to merge droplets using AC 
electric field. AC electric field disturbs the inter-droplet interface and destabilizes 
the interface even in the presence of surfactants (13). Also, the 
compression/decompression dynamic of the droplet at an expansion geometry 
helps with the destabilization of the droplet interface (15). 
The electrocoalescence module used in the project consist of an expansion 
chamber, a pair of parallel chromium-gold electrodes that are 30 µm apart with 
50 µm widths, and 3 µm thick dielectric PDMS layer for preventing inter-droplet 
contamination. Square-shaped AC electric field was used to merge the droplets. 
Voltage and frequency were tuned to obtain stable operating conditions. 
Operating voltages were from 7 V to 20 V with the operating frequency ranging 
from 1 kHz to 100 kHz. During high throughput screening experiments, droplet 
 
 
 
 
 
 
 
Figure 4.15.  (a) Droplet electrocoalescence under AC electric field. (b) Non-coalescence of droplets 
at the microfluidic expansion channel without electric field. 
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electrocoalescence was achieved using a 7 V square shaped AC electric field with 
1 kHz frequency whilst maintaining a one-to-one droplet fusion ratio. This 
corresponds to the electric field density of 1400 Vcm-1. Figure 4.15 (a) shows 
sequential pictures of droplet electrocoalescence process under 7V AC field while 
Figure 4.15 (b) shows that no droplet coalescence happens under the absence of 
electric field.  
 4.4.5. Microfluidic Incubation 
After the electrocoalescence of droplets, they need to be incubated in order to 
allow the viability assay to fluorescently label the photosensitised cells within the 
droplet. The incubation time for the viability assay was around 25 minutes (4) so 
a delay line capable of incubating droplets for 30 minutes was designed and 
tested. The delay line, 1000 µm wide, 260 µm deep and 31 cm long, has a wide 
channel cross-section in order to reduce the back pressure within the system. 
Although this induces droplet residence time distribution, high aqueous volume 
fraction of over 0.5 was used during the experiments to allow droplets to form 
close packing structure. By close packing droplets, droplets flow through the 
delay line while locked in contact with each other which reduces the droplet 
residence time dispersion. With 260 µm channel depth, droplets (~1.5 nL) flow 
through the device in double layers. In this incubation channel, the upper layer is 
always close packed under most of the flow conditions as the droplets are lighter 
than the continuous phase. The lower droplet layer is less densely packed and 
droplets can flow through faster than the upper droplet causing droplet residence 
time distributions. The droplets can be more tightly packed by increasing the 
droplet volume fraction and this is shown in Figure 4.16. Droplets located in 
different layers were labeled by different colours (red for the top layer and yellow 
for the bottom layer) and tracked for a while in order to observe the droplet flow 
profile on both the top and the bottom layer. Figure 4.16(a) shows the droplet 
flow profile at 33% droplet volume percentage. In this case, a large difference in 
the residence time (~22%) was observed between the droplet layers. In fact, a 
droplet was observed to flow 1.5 times faster than the droplets that were locked  
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Figure 4.16.  Droplet flow within microfluidic incubation channel with 260 µm depth and 1000 µm 
width at droplet volume percentage of (a) 33%, (b) 50%, and (c) 66%. The droplets 
highlighted with red pointers are the ones at the top droplet layer while the ones 
highlighted with yellow are at the bottom. Scale bar indicates 100 µm.  
together at the upper layer. When the droplet volume fraction was increased to 
50%, droplets flowed locked against each other on both the upper and the lower 
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layer (Fig. 4.16(b)). In this case, a small inter-layer shift was still observed but 
the droplet residence time was much smaller than the ones with lower droplet 
volume fraction. Finally, when the droplet volume fraction was further increased 
to 66%, the droplets were tightly locked together and no droplet flow velocity 
differences were observed between droplets (Fig. 4.16(c)). As droplets are flowing 
in two layers, droplets can also move between layers. Mostly, droplets from the 
bottom layer would migrate to the top layer if there is enough space on the top 
layer as the droplets are lighter than the continuous phase. This process would 
reduce the droplet residence time distribution. 
4.4.6. Viability Assay Scoring Chip 
Combining all these microfluidic modules, the cell viability scoring device 
consists of i) droplet synchronization modules consisting of a droplet reinjection 
nozzle (Figure 4.17A) and a droplet generation module, ii) an electrocoalescence 
module (Figure 4.17B) with an expansion geometry and a pair of electrodes 
spaced 30 µm apart, iii) a wide droplet incubation channel (Figure 4.17C) with 
incubation time  
 
 
 
 
 
 
 
 
Figure4.17.  Microfluidic cell viability scoring device consisting of A. cell containing droplet 
reinjection, B. Droplet electrocoalescence, C. Droplet incubation channel, D. 
Fluorescence detection channel. 
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Figure 4.18.  Schematic of the droplet based microfluidic photosensitiser screening platform. A. 
E.coli cells and photosensitisers are encapsulated into droplets. B. Droplets are 
collected in a microfluidic TPE chamber for dark incubation and light exposure. C. 
Light exposed droplets are reinjected from the chamber into the viability scoring device. 
D. Two aqueous droplets, the smaller droplet containing cells and photosensitiser and 
the larger one containing the viability assay mixture, are merged using AC-electric field. 
E. Fused droplets are then incubated within a delay line for 25 minutes before 
fluorescence detection.  Scale bars indicate 50 µm. 
of 30 minutes, and iv) a fluorescence detection module with shallower channel for 
a sensitive detection (Figure 4.17D). 
4.5. Microfluidic platform for photosensitiser screening 
Figure 4.18 shows schematics of the integrated microfluidic platform for 
photosensitiser screening allowing for i) the encapsulation of cells and 
photosensitizers in pico-litre sized compartments (Fig. 4.18A), ii) simultaneous 
irradiation of tens of thousands of these droplets (Fig. 4.18B), iii) reinjection of 
light exposed droplets (Fig. 4.18C), iv) electrocoalescence of reinjected droplets 
with droplets containing viability assay mixture (Fig. 4.18D) and v) a microfluidic 
incubation line for viability scoring of the exposed samples (Fig. 4.18E).  
The cytotoxicity screening workflow consists of four key steps. First, microdroplets 
containing cells and photosensitizer are generated using FC40 containing 1.8% 
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custom synthesized PEG-PFPE triblock biocompatible perfluorinated polymeric 
surfactant. T-junction geometry (Fig. 4.18A) was employed in order to encapsulate 
cells and photosensitisers in 140 pL droplets. As cell containing solutions have 
tendency to wet the micro channel surface during droplet generation, the 
microfluidic device was flushed with Aquapel for 5 minutes to hydrophobically 
coat the channel and flushed with FC-40 oil in order to facilitate stable droplet 
formation.  
These droplets are then aliquoted into large thermoplastic microfluidic chambers 
(2 mm x 4 mm x 260 µm) for dark incubation and light exposure purposes as 
shown in figure 4.18.B. The microfluidic chamber is fabricated using rigid TPE 
material. TPE is suitable for fabricating microfluidic chamber device capable of 
collection, light exposure and reinjection of droplets under high pressure as it has 
a strong UV absorption, high transmission of visible light (over 90 % 
transmittance at 600 nm), and a large Young’s modulus value (16). These 
microfluidic chamber devices are fabricated using hard thermoset polyester 
material with much larger Young’s modulus value (3.8 GPa) than PDMS (~4 MPa) 
to avoid expansion of the device material so that the droplets can be loaded into 
the microfluidic chamber using high flow rates (>40 µl/min) within 10 minutes and 
reinjected into another device without significant expansion. Also, a large pillar 
with 5.15 mm radius was erected at the middle of the chamber to provide a solid 
support to further minimize the expansion and distortion of the device during 
reinjection and droplet loading process. The collected droplets are then incubated 
in dark, and exposed to light in the microfluidic chamber. This microfluidic 
chamber allows simultaneous incubation and light exposure of millions of droplets 
from tens of minutes to days without any device failures. Droplets can then be 
reinjected into another device for further processing by simply pushing droplets 
with oil. Within the device, as aqueous phase is lighter than oil, droplets can be 
closely packed for reinjection by turning the device up. By doing so, droplets float 
on top of the oil and can be reinjected into another microfluidic device in an 
orderly fashion as shown in Figure 4.18.C. Also, it is possible to deliver oxygen to 
the droplets through perfusion of oil fully saturated with oxygen and as FC40 has 
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a higher density of 1.87 gL-1 compared to water (1 gL-1), droplets were kept within 
the microfluidic light exposure chamber by slightly tilting the device so that the 
gravity would counterbalance the hydrodynamic force and prevent droplets from 
exiting the chamber along with the oil flow.  
After light exposure within the chamber structure, droplets were reinjected into 
the third microfluidic device for viability scoring. The viability scoring device 
consists of four main modules. (i) The photosensitised cell containing droplets are 
reinjected into the microfluidic device via reinjection nozzle and spaced out evenly 
by the oil (Fig. 4.17A). In the meanwhile, fluorescent viability assay dyes are 
encapsulated into 1.5 nL droplets at 10-20 Hz frequency. (ii) Droplets with cell 
suspensions are merged with those containing viability assay using 
electrocoalescence (Fig. 4.17B). This module consists of an expansion geometry, a 
pair of parallel chromium-gold electrodes that are 30 µm apart with 50 µm widths, 
and 3 µm thick dielectric PDMS layer for preventing inter-droplet contamination. 
Using this system, droplet electrocoalescence was achieved using a 7 V square 
shaped AC electric field with 1 kHz frequency whilst maintaining a one-to-one 
droplet fusion ratio. (iii) Droplets are then incubated in a delay line with large 
channel cross-section, 1000 µm wide, 260 µm deep and 31 cm long, to reduce the 
back-pressure (Fig. 4.17C). This approximately gives an incubation time of 25 
minutes for a total flow rate of 4 µlmin-1 allowing the enzymatic reaction to fully 
develop on-chip. Although wide channels induce droplet residence time dispersion, 
this was reduced significantly by using higher oil volume fraction. (iv) After 
incubation, the droplets pass through a fluorescence detection point with a 
shallower channel than the incubation channel for more sensitive detection. Two 
avalanche photodiode detectors coupled with 488 nm laser excitation source were 
used to analyze the fluorescence traces from droplets. This system is capable of 
resolving single fluorophore events at frequencies in excess of 100 kHz (17). 
A modular, droplet-based microfluidic platform was developed for performing 
high-throughput cytotoxicity screening of photosensitising conditions against 
E.coli cells. This platform is capable of generating droplets containing cells and 
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photosensitisers, incubating them under various doses of light, and detecting the 
fluorescence traces from the photosensitised cells in high throughput manner and 
using extremely small quantities of reagents.  
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Chapter 5. Microfluidic Viability Scoring  
This chapter presents the development of on-chip viability assay for E.coli cells 
within droplet microfluidics. Firstly, several viability assays such as SYTO-9, 6-
CFDA and PI were tested for E.coli staining using bulk fluorescence detection 
methods such as fluorescence microscope and well-plate fluorescence detection. 
Then the viability assays were assessed using the microfluidic confocal 
fluorescence detection and the effects of various reagents such as Luria-Bertani 
Broth, and glutaraldehyde on the viability assay performance were investigated. 
Finally, the assays were tested using the microfluidic viability scoring device and 
a suitable viability assay combination (6-CFDA and PI) was chosen for 
performing droplet based microfluidic viability screening experiments.  
5.1. E.coli  cell preparation for microfluidic detection 
Cell density and cell droplet occupancy are important parameters for the 
microfluidic high throughput screening experiments. For instance, cell density  
 
 
 
 
 
 
 
 
 
Figure 5.1.  Cell density calibration using absorbance measurements at 600 nm. 
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can affect the efficacy of the drug depending on the drug type as well as affecting 
the droplet occupancy which can have a large effect on the sensitivity of the 
detection system as well as the droplet generation stability. If too many cells are 
present in a droplet, the microfluidic cell viability detection becomes less 
sensitive because the neighbouring cell signals are too close to each other which 
reduce the resolution of the detection system. Thus, accurate measurements of 
the cell density before each screening and characterization experiments are 
important for enhancing the cell viability measurement sensitivity and adjusting 
the cell occupancy within a droplet of certain size.  
To this end, E.coli cell density was calibrated using the optical density 
measurements (Fluoromax-2, Horiba Scientific., USA), and colony forming unit 
counting method. Firstly, E.coli cells were grown overnight in LB Broth at 37°C 
and 200 rpm shaking rate. Then a stock solution was prepared by centrifuging 
the cell suspension at 1000 rpm for five minutes and resuspending the cells in 
PBS. This stock sample was then characterized by measuring the absorbance 
value at 600 nm which was 1.16 for the stock sample. The stock solution was 
then serially diluted by 2x and the absorbance was measured at 600 nm for each 
dilution. In the meanwhile, a plain nutrient agar was prepared by dissolving 9.1 
g tryptone, 4.6 g yeast extract, 4.6 g NaCl, and 13.7 g agar in 1 L DI water. The 
agar solution was then autoclaved and cooled down for an hour before pouring 
them onto standard sized petri dishes. The petri dishes were then kept in a 
sterile hood for awhile in order to solidify the agar poured onto the plates. The 
stock sample was then serially diluted by 10 folds down to 7 orders of magnitude 
and 10 µl of each diluted samples were plated onto the agar plate and incubated 
in a 37 °C room placed upside down for a day in order to allow the growth of 
visible E.coli colonies.  
Afterwards, the number of colonies in the agar plates was counted in order to 
estimate the number of colony forming units within the stock solution. As 220 
colonies were counted at 10,000-fold dilution, the number of colony forming 
units/ml in a stock solution was estimated to be 2.2 X 109 cfu/ml.  Figure 5.1 
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shows the plot of the number of colony forming units per ml against the 
absorbance value. Absorbance value at 600 nm was found to be linearly 
proportional to the cell density and proved to be a simple and reliable method of 
estimating the cell density. 
5.2. Choice of Viability Assay 
In order to evaluate the efficacy of the PDT photosensitisers, a suitable viability 
assay had to be found for distinguishing dead cells from live cells. Different types 
of viability assays are currently available using various detection methods such 
as luminescence (1), absorbance (2), and fluorescence detection (3). Most of the 
assays are optimized for the micro-well plate based measurements and their 
sensitivity, specificity and performance had to be further tested within droplet 
formats. As droplet based microfluidic fluorescence detection is well documented 
in the literature (4, 5) and is capable of detecting single cells which allow the 
measurement of both viable and non-viable cell numbers, several viability assay 
based on fluorometric detection were investigated such as SYTO-9, DIO, 
Propidium Iodide and CFDA. The assays were characterized using various 
methods such as micro-well plate measurements, microscopic images, and 
microfluidic measurements, and suitable combinations of viability assay mixture 
was found for the microfluidic high throughput screening experiments.  
5.2.1. SYTO-9 and Propidium Iodide 
First, Baclight viability assay (Invitrogen, UK) consisting of SYTO9 and 
propidum iodide was evaluated. Both are popular fluorescent DNA-intercalating 
dyes used in micro-well plate and flow cytometry based cytotoxicity 
measurements. Their fluorescence intensity increases by 20 fold upon binding to 
DNA. SYTO9 is a green fluorescent dye that is membrane permeable while 
propidium iodide is a red fluorescent dye which is membrane impermeable. Thus 
live cells fluoresce green while dead cells with compromised cell membranes 
exhibit both green and red emission. SYTO9 has excitation and emission maxima 
of 475 nm and 510 nm, respectively (Fig. 5.2.(a)), while propidium iodide has  
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Figure5.2.  Fluorescence and absorbance spectra of (a) SYTO9 and (b) Propidium Iodide in DI 
water.  
 
 
 
(a) 
(b) 
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Figure 5.3.  (a) Fluorescence images of live (Left) and dead (Right) E.coli cells stained by SYTO9 
and PI. (b) Fluorescence spectra of live and dead E.coli cells stained using 4 µM 
SYTO-9. (c) Fluorescence spectra of Live and dead E.coli cells stained with 1 µM 
Propidium Iodide. 
 
(a) 
(b) 
(c) 
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excitation and emission maxima of 500 nm and 630 nm, respectively (Fig. 5.2.(b)). 
Thus the confocal laser excitation source (488nm) in combination with the APD 
detectors fitted with two filter sets (Green channel: 500-530 nm, Red channel: 
>630 nm) would be suitable for differentiating between green and red signals.   
Then, the fluorescence images and spectra of live and dead cells labeled with 
SYTO-9 and propidium iodide were taken in order to test the fluorescence 
intensity increase of the assay upon binding to the DNA within the cells. Dead 
cells were prepared by treating cells with methanol for five minutes and 
resuspending the cells in PBS. Figure 5.3.(a) shows fluorescence microscopic 
images of cells labeled with SYTO-9 and propidium iodide using an inverted 
fluorescence microscope (Olympus BX51, UK) fitted with 488 nm excitation light 
source. As expected, live cells exhibit only green fluorescence while red cells 
exhibit both green and red fluorescence (Fig.5.3.(a)).  
The fluorescence intensity increase was further demonstrated by taking 
fluorescence spectra of the SYTO-9 and propidium iodide using a commercial 
fluorescence spectrometer (Fluoromax 2, SPEX, Instruments SA, USA) and 
comparing them with the fluorescence intensity of the assays bound to both live 
and dead cells as shown in Figure 5.3.(b). While both live and dead cells exhibit 
green fluorescence increase, the signal was stronger for the dead cells. This is 
because live cells have intact membrane compared to compromised dead cell 
membrane. The endocytoplasm of dead cells leaks out to the media which binds 
to SYTO-9 increasing the green fluorescence. Nonetheless, both live and dead 
cells exhibit green fluorescence regardless of the fluorescence intensity difference. 
Dead cells bound to propidium iodide also show significant increase of the red 
fluorescence intensity (600nm) compared to live cells (Fig.5.3(c)). The bulk 
fluorescence measurements and images show good bulk staining performance of 
the viability assay for scoring dead and live cells. 
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Figure. 5.4.  Microfluidic viability signal detection (a) Two-inlet T-junction microfluidic droplet 
generation device used for scoring dead and live cells. Scale bar indicates 1 mm. 
Fluorescence traces of the droplets containing fluorescently stained (b) dead and (c) 
live E.coli cells flowing through the microfluidic device for 0.5 second. Periodic 
droplet background signals are analyzed so that droplet boundaries are highlighted 
using dotted lines while cell signals above the boundary were highlighted in circles. 
 
(a) 
(b) 
(c) 
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5.2.2. Microfluidic fluorescence traces of cells labeled with Baclight assay 
Firstly, E.coli cell samples in Lauria Bertani (LB) broth  were treated with 1 µM 
SYTO-9 and 1 µM Propidium Iodide off chip and then injected into a two-junction 
microfluidic droplet generation device (Fig. 5.4.(a)). Mineral oil (Sigma-Aldrich, 
St. Louis, USA) with 5% w/w ABIL EM90 Surfactant (EVONIK Goldschmidt 
GmbH, Essen, Germany) was used as the continuous phase for generating 
droplets containing the cell suspensions. The oil flow rate of 1 µl/min and 
aqueous flow rate of 0.5 µl/min was used for generating droplets. As expected, the 
dead cells showed red and green peaks together while live cells exhibited only 
green signals. The data were processed using an in-house Matlab program 
developed by Dr. Edel. Using this program, droplet boundaries are plotted as 
dotted lines and spikes above the droplet boundaries are defined as fluorescence 
signals from cells. Typical fluorescence traces of dead and live cells in 
microfluidic droplets for 0.5 seconds are shown below in Figure 5.4(b) and (c).  
5.2.3. The effects of LB broth 
The use of LB Broth for defining droplet boundary within microfluidic channel 
was reported previously (5). As SYTO-9 is almost non-fluorescent within the 
droplets, LB media was added to the mixture to act as a weakly fluorescing 
background defining the aqueuous droplet boundaries. 
Live and dead cells were prepared as described before and resuspended in LB 
media. The optical densities of the cell suspension were adjusted to 1.25 so that 
the cell density was the same in all solutions. Mixtures of dead and live cells were 
prepared and 300 nM SYTO-9 and 1 µM Propidium Iodide were added to the 
mixture and incubated for 10 minutes off chip in order to allow the viability assay 
to fully fluorescently label the cells. They were then injected into microfluidic 
droplet generation device (Figure 5.4.(a)) for viability scoring. Fluorescence traces 
were measured using 600X magnification for a period of one minute for 
quantitative scoring of dead (green and red fluorescence peak) and live (green 
fluorescence) cells. 
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Figure. 5.5.  Microfluidic confocal fluorescence detection of E.coli cells stained by SYTO-9 and 
Propidium Iodide in LB media. (a) The variation in the total number of SYTO-9 
stained cells (green fluorescence) detected at varying mixtures of dead and live cells 
with the same cell density. (b) Red/Green ratio at different dead cell proportions. 
(a) 
 
(b) 
(a) 
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increasing dead cell proportion. Red/Green ratio should be proportional to the 
As the optical density was matched to 1.25 for all samples prior to experiments, 
the total number of cells for each measurement is expected to be the same for all 
samples and the red to green peak ratio is expected to increase linearly with 
increasing dead cell proportion. Red/Green ratio should be proportional to the 
percentages of dead cells within the cell population considering that SYTO-9 
stains both dead and live cells while PI stains only dead cells. Figure 5.5.(a) shows 
different detection sensitivities of SYTO-9 labelled cells with different live and 
dead cell compositions. This leads to incorrect estimation of the proportion of dead 
cells for mixtures of live and dead cells (Figure 5.5.(b).  
Figure 5.5.(a) shows a linear increase of the total number of cells detected for 
increasing dead cell population. As the total number of cells was kept the same for 
each mixture by matching their optical density, this is an incorrect measurement 
and suggests higher sensitivity of SYTO-9 labeled dead cells compared to live cells. 
In fact, only 500 live cells were detected compared to 3400 dead cells at the same 
optical density. This is because dead cells have ruptured cell membranes which 
enable SYTO-9 to more easily penetrate into the cell compared to live cells with 
intact membranes. This is also shown in Figure 5.3.(b) where dead cells show 
almost nine-fold higher fluorescence intensity than live cells when fluorescently 
labeled with 4 µM SYTO-9. Furthermore, SYTO-9 binds to LB media which 
increases the background signal of the droplets by 30 times compared to LB broth 
(Fig.5.6.(a)) and decreases the fluorescence detection sensitivity of cell signals. As 
live cells generally have weaker fluorescence, they are affected more by this than 
dead cells. This apparent difference in the detection sensitivity leads to incorrect 
overestimation of the dead cell proportion for live and dead cell mixtures (Fig. 
5.5.(b)). In fact, the microfluidic scoring result show that 90% of the cells were 
scored as dead contrary to the fact that just 25% of the cells in the sample were 
dead.  
Various fluorescence spectra of SYTO-9 in different media were taken (Fig. 5.6.(a)). 
4 µM SYTO-9 in LB Broth exhibit significantly stronger fluorescence emission  
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Figure 5.6. (a)  Fluorescence spectra of SYTO-9 in LB Broth, PBS, and dead cell suspension. (b) (i) 
Transmission and (iii) fluorescence images of SYTO-9 stained E.coli cells in PBS. (ii) 
Transmission and (iv) fluorescence images of SYTO-9 stained E.coli cells in LB Broth. 
LB Broth medium shows enhanced fluorescence background signals compared to PBS. 
  
 
(a) 
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compared to SYTO-9 in PBS or water. Figure 5.6.(b) shows fluorescence images of 
live cells suspended in either PBS or LB Broth stained with 4 µM SYTO-9. As 
expected from the fluorescence spectra (Fig. 5.6.(a)), SYTO-9 in LB Broth exhibit 
much higher fluorescence background signal than PBS. Thus, LB broth could have 
negative effects on the fluorescence detection sensitivity significantly due to high 
background noise. Hence, LB media was not used in the subsequent sections for 
any of the well-plate and microfluidic viability scoring experiments. 
5.2.4. Off chip viability staining 
SYTO-9 and Propidium Iodide performance was successfully tested on 96 micro-
well plates. E.coli cells were prepared overnight in a shaking incubator, 
centrifuged, and resuspended in PBS with the optical density of 0.25 in order to 
prepare live and dead cell suspensions with the same cell density. Then 100 µl of 
each of live and dead cell suspensions were aliquoted into 96 micro-well plate 
with 4 µM SYTO-9 and 4 µM Propidium Iodide. After 20 minutes incubation time, 
red and green fluorescence intensities of the mixtures were measured using 
Fluorometric1, a 96-well fluorometric plate reader. As shown in figure 5.7.(a), a 
linear increase in the red/green fluorescence signal ratio with increasing dead cell 
proportions was observed.  
The viability assay comprising of SYTO-9 and propidium iodide was also 
successfully characterized in microfluidic droplet format, allowing interrogation 
of both dead (green and red fluorescence) and live (green fluorescence) E.coli cells 
when the viability assay was added off-chip prior to microfluidic detection (Fig. 
5.7.(b)). A two inlet microfluidic droplet generation device was used for droplet 
generation (Fig 5.4.(a)) and a confocal fluorescence microscope with 488 nm laser 
excitation source was used for highly sensitive fluorescence detection. Cell 
suspensions with optical density of 0.25 were prepared and 4 µM SYTO-9, 4 µM 
propidium iodide and 4 nM Alexa Fluor 488 (AF-488) was added to the mixture 
for fluorescence staining. Note that 4 nM AF-488 was added instead of LB broth 
in order to fluorescently label droplets for droplet analysis purposes. The 
fluorescently labeled cell suspension and FC-40 oil with 1.8% fluorinated  
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Figure 5.7.  (a) Red/Green fluorescence intensity ratio at different dead cell proportions measured 
using well plate reader. (b) Red/Green fluorescence peak ratio detected using 
microfluidic confocal fluorescence detection for varying dead cell proportions. 
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Figure 5.8.  (a) Fluorescence traces of droplets containing SYTO-9 labelled E.coli cells without 
SYTO-9 adhesion to the channel wall over 0.1 second. (b) Frequency of the 
fluorescence counts for the fluorescence traces shown in Figure 5.8.(a). (c) 
Fluorescence traces of droplets containing SYTO-9 labelled cells with SYTO-9 
adhesion to the channel wall. (d) Fluorescence count frequency of the fluorescence 
traces shown in Figure 5.8.(c) 
surfactant were then injected into the microfluidic device using Harvard PHD 
syringe pump at a flow rate of 1 µl/min for fluorescence detection. Approximately 
20 % of the cells out of the live cell population were scored as dead (Fig. 5.7.(b)) 
which is in agreement with many of the previous studies reported on the cell 
viability in microdroplets (4, 6). According to the literature, 10-20 % losses in the 
cell viability are expected due to shear stress during droplet formation process (4). 
The well plate and microfluidic viability scoring results showed an excellent 
performance and SYTO-9 and propidium iodide combination is a good viability 
(a) 
(c) 
(b) 
 
(d) 
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assay combination for fluorescently labeling the live and dead E.coli cells for bulk 
experiments. 
5.2.5. Problems with on-chip incubation 
Unfortunately, the viability assay combination, SYTO-9 and propidium iodide, 
was found to lose their activity once they were encapsulated within the droplets. 
There were two major problems, adhesion of SYTO-9 to channel walls and the 
inability of the assay to fluorescently stain E.coli cells within droplets.  
In fact, the adhesion of SYTO-9 to microfluidic channel was a problem for all the 
viability scoring experiments including the ones where E.coli cells were stained 
by STYO-9 off-chip prior to injection into the microfluidic devices. Even when 
SYTO-9 was encapsulated within droplets, SYTO-9 somehow leaked out from the 
droplets to stick to the channel walls.  Figure 5.8 shows the fluorescence traces of 
droplet signature for 0.1 second with (Fig. 5.8.(a)) and without SYTO-9 adhesion 
(Fig. 5.8.(c)). The measurement without SYTO-9 adhesion was taken using a 
fresh microfluidic device preconditioned with oil and surfactant for 30 minutes 
while the measurement with SYTO-9 adhesion was taken after 2 hours of 
microfluidic device operation time. The background noises were 3 and 10 
fluorescence counts per millisecond for (a) without SYTO-9 adhesion and (c) with 
SYTO-9 adhesion, respectively. In both cases, 4 µM SYTO-9, 4 µM Propidium 
Iodide, and 4 nM AF-488 were used as the viability assay mixture and mixed 
with E.coli cells prior to microfluidic injection. Figure 5.8.(b) and (d) plot the 
frequency of the fluorescence counts for fluorescence traces shown in (a) and (c), 
respectively. They show the same observation where background signal for micro 
channel with significant SYTO-9 adhesion was significantly higher than that of 
the one without the adhesion.  
In some cases, the background noise was much higher than the droplet signals 
which made it impossible to take any measurements from the contaminated 
microfluidic device despite the fact that the use of droplets normally inhibits the 
adhesion of biomolecules to the channel wall through encapsulation. The  
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Table 5.1.  The effects of various PDMS surface treatments on the background fluorescence signal 
by SYTO-9 adhesion to the microfluidic channel wall.  
background signal varied widely between microfluidic measurements depending 
on the surface pre-treatment, device operation time, the concentration of SYTO-9, 
device material and laser intensity. In particular, the surface pre-treatment was 
found to be an important factor for reducing the adhesion of SYTO-9 to the 
channel wall. Table 5.1 shows the extent of SYTO-9 adhesion for PDMS surfaces 
treated using various surface treatment methods. In order to test this, 
microfluidic devices were fabricated, and treated with various surface treatment 
methods such as Aquapel, 0.2% Trichlorosilane in FC40, 100 µg/ml Bovine Serum 
Albumin (BSA), 1% pluronic P105  and 1% pluronic F108 in DI water for 5 
minutes. Aquapel and 0.2% Trichlorosilane are typically used for hydrophobic 
glass surface coating, BSA is frequently used for microfluidic surface coating for 
reducing biomolecule interaction with the channel wall, and Pluronic P105 and 
F108 are polymers which inhibits the biomolecule adhesion to various types of 
surfaces. After flushing the device with DI water for 5 minutes, 10 µM SYTO-9 
aqueous solution was flowed through the devices for 5 minutes at a flow rate of 
10 µl/min and washed with DI water in order to remove any remaining unbound 
SYTO-9.  
Surface Treatment Background Noise (Counts/sec) 
PDMS 400 
SYTO-9 15000 
Aquapel 240,000 
0.2% Trichlorosilane 100,000 
100 µg/ml BSA 130,000 
1% P105 14,000 
1% F108 6,000 
 
126 
 
488nm laser was then focused onto a tight spot at the channel surface in order to 
take SYTO-9 adhesion measurements using confocal microscope. The results 
show that when no SYTO-9 was applied, the background fluorescence signal was 
around 400 photon burst counts per second. After SYTO-9 is introduced, the 
background noise rose up to 14,000 photon burst counts per second. When the 
microfluidic channel was pre-treated using hydrophobic coating agents such as 
Aquapel, and 0.2% Trichlorosilane in FC-40, the adhesion of SYTO-9 to the 
channel wall increased by 10 folds and more. Bovine Serum Albumin (BSA) is 
frequently used for reducing the interaction of the biomolecules with the channel 
walls but the adhesion of SYTO-9 increased by 10 folds when the device surface 
was pre-treated with 100 µg/ml BSA. In fact, BSA binds to SYTO-9 which 
enhances the fluorescence signal significantly. Pluronic derivatives such as P105 
and F108 are frequently used for reducing the adhesion of biomolecules to the 
channel walls for microfluidic applications (7). Surface coating using 1% pluronic 
F108 was found to reduce SYTO-9 adhesion to channel walls by 2.5 times.  
1.8% Raindance EA surfactant in FC-40 was also used to treat the surface. This 
method was found to be the most effective among the surface treatment methods 
tested and was used for subsequent microfluidic high throughput screening 
experiments using SYTO-9. In fact, when the microfluidic device was flushed 
with 1.8% Raindance surfactant in FC-40, the device operation time was found to 
be over a few hours compared to just a few minutes for untreated devices. SYTO-
9 adhesion was also found to be dependent on the device material and PDMS-
PDMS devices were used instead of PDMS-Glass devices in order to increase the 
device operation time. 
Having found a way to avoid the adhesion issues, SYTO-9 and propidium iodide 
were tested for on-chip viability scoring. As shown in Figure 5.9, a 4 inlet flow 
focusing droplet generation microfluidic device with short incubation module (a) 
and an integrated microfluidic viability scoring device (b) were used for testing 
on-chip viability assay incubation with E.coli cells. 
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The microfluidic device shown in Figure 5.9.(a) has four aqueous inlets for 
introducing viability assay mixture containing 8 µM SYTO-9, 8 µM Propidium 
Iodide and 8 nM AF-488, PBS, and E.coli cell suspensions. They are then 
encapsulated in 200 pL droplets, mixed in the serpentine mixing module and 
incubated within a wide incubation channel (250 µm width, 60 µm depth) capable 
of incubating droplets for 10 minutes. Furthermore, the microfluidic device has 
an additional oil inlet for introducing continuous phase for spacing out droplets in 
order to reduce the dispersion between droplet incubation time. After droplet  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 5.9.  (a) Microfluidic device capable of incubating droplets for 10 minutes with small 
fluorescence detection window in the middle of each incubation channel. (b) 
Microfluidic viability scoring device consisting of droplet generation, 
electrocoalescence, 30 minutes incubation channel and a fluorescence detection 
channel. 
 
(a) 
(b) 
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formation, fluorescence signals from the droplets were detected after various 
incubation time using narrow fluorescence detection channels incorporated at the 
middle of the incubation channels. Unfortunately, no fluorescence cell signals 
were detected using this microfluidic incubation device.  
In order to see if the incubation time was too short for fully labeling cells, an 
integrated microfluidic device consisting of two droplet generation modules, an 
electrocoalescence module, a long delay line, and a detection module, was used for  
testing the on-chip viability scoring. The device is fabricated using multi-layer 
photolithographic method where channels with different thicknesses were 
manufactured within a single microfluidic device. The droplet generation, 
electrocoalescence module and the detection channel are 80 µm deep while the 
incubation channel is 260 µm deep, 1000 µm wide and 31 cm long allowing 
droplet incubation time of over 30 minutes. At the detection channel, additional 
channel for introducing oil phase is included in the design in order to reduce 
SYTO-9 adhesion to the channel walls. 
Despite the fact that the device allowed sufficient droplet incubation time as 
determined using various bulk calibration experiments, SYTO-9 was not able to 
stain E.coli cells once encapsulated within droplets. This is because SYTO-9 loses 
its activity within droplets. There are two major evidences for this; 1) SYTO-9 
leaks out of droplets to stick to the channel wall, and 2) SYTO-9 does not 
fluoresce within droplets although it is fluorescent in bulk solution. SYTO-9 was 
not active in all of the oil/surfactant combinations tested, FC-40, HFE-7500,  
 
 
 
 
Figure 5.10.  Chemical Structure of 6-CFDA. 
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Figure 5.11.  6-CFDA fluorescence spectrum with and without E.coli cell. 
mineral oil and Isopropyl myristate. Thus, SYTO-9 was found to be only suitable 
for testing E.coli viability within bulk conditions and a new viability assay 
combination had to be found for assessing the viability of E.coli cells within 
droplet based microfluidic platform.   
5.3. Carboxyfluorescein diacetate 
Carboxyfluorescein diacetate (Invitrogen, UK) has been widely employed as a 
fluorogenic indicator of bacterial esterase activity (3). This hydrophobic 
compound (Figure 5.10) diffuses through the cell membrane into the cytoplasm 
where it is hydrolyzed by intracellular non-specific esterase, producing a green 
fluorescent product, carboxyfluorescein (CF). Because phospholipids bilayers are 
permeable to hydrophobic molecules, CFDA, a hydrophobic molecule, can diffuse 
into the cell across the cell membrane while CF is hindered from diffusing out of 
the cell due to its hydrophilic property. So CF is retained within the cells with  
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Figure 5.12.  (a) A transmission brightfield image and (b) a fluorescence image of E.coli cells 
stained with 2 µM 6-CFDA. (c) A transmission image and (d) a fluorescence image of 
E.coli cells stained with 2 µM 6-CFDA and GTA. 
high intracellular esterase activity and they fluoresce green (8). On the other 
hand, CF is not retained within the cells with damaged cell membrane and these 
cells do not exhibit any fluorescence by CFDA.  Thus when CFDA is used along 
with PI for staining bacterial cells, live cells fluoresce green while dead cells 
exhibit only red fluorescence signals. Figure 5.11 shows the fluorescence 
spectrum of 2 µM 6-CFDA using Nanodrop 3300 (Thermo Fisher Sci Inc., USA) 
with 488 nm excitation source. 6-CFDA has emission maximum of 515 nm and 
live cells show large increase in the fluorescence intensity due to esterase activity.  
5.3.1. CFDA intake 
The extent of CF-retention in viable cells depends on the cell type. In addition, 
E.coli cells, Gram-negative bacteria, have an outer membrane which is 
impermeable to 6-CFDA. Therefore, 6-CFDA is not able to permeate into the  
 
(a) (b) 
(c) (d) 
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Figure 5.13.  Fluorescence spectra of live cells stained with 2 µM 6-CFDA with (red) and without 
(black) GTA.   
E.coli cells which results in underestimation of the viable cells within the cell 
population when scored using 6-CFDA. In fact, very small number of cells were 
detected within microfluidic devices when E.coli cells were treated with 6-CFDA 
alone. In order to overcome this, glutaraldehyde (GTA) was used in order to 
facilitate permeation of CFDA into cells and inhibit CF leakage from E.coli cells 
(3, 8).  GTA is a classical cross-linking reagent that reacts with free amine groups 
in the bacterial cell and the elimination of the hydrophilic free amine groups 
cause the structural disorganization in the membrane which facilitates CFDA 
permeation into the cell. On the other hand, the cross linking of GTA with the 
mucopeptides in peptidoglycan make the membrane more hydrophobic and 
prevents hydrophilic CF from diffusing out of the cell. This facilitates the efficient 
staining of esterase-active bacteria with CFDA and enables straightforward 
discrimination of viable and dead cells using fluorescent microscopy (8). Figure 
5.12 show transmission and fluorescence images of live cells stained using 2 µM 
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CFDA (a, b) and 2 µM CFDA and 1g/l GTA (c, d). As expected, live cells stained 
with mixtures of 2 µM CFDA and 1 g/l GTA exhibit stronger fluorescence signals 
compared to 2 µM CFDA. Almost all cells were stained green when 1 g/l GTA was 
added to the mixture while only two cells are fluorescent for the sample without 
GTA. This is also shown in the fluorescence spectra of live cells stained with 
CFDA and GTA (Fig.5.13.(a)) and just CFDA (Fig.5.13(b)) where addition of 1 g/l 
GTA enhances the fluorescence signal by 50%.  
5.3.2. Optical Filter 
 
 
 
 
 
 
 
Table 5.2.  Effect of optical filter on dead cell detection. 
Previously, the confocal spectrometer had two APD detectors fitted with two 
optical filters; green (500-550nm, Model name) and Red (630nm~). When these 
optical filter sets were used, significant portion of red fluorescence signal from PI 
leaked into green detection channel which led to significant number of green 
fluorescence signals being detected for dead cell populations. In fact, propidium 
iodide has a relatively strong fluorescence emission around 550 nm and nearly 
255 cells were detected in the green fluorescence detection channel out of 1187 
red cells which is 20% of the whole cell population (Table 5.2). Furthermore, 96% 
of green fluorescence bursts for dead cell samples were coincident with red 
fluorescence bursts which points to the fact that PI fluorescence is leaking into  
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Figure 5.14.  (a) A transmission image, (c) a green fluorescence image, and (e) a red fluorescence 
image of dead E.coli cells stained with the viability assay mixture. (b) A transmission 
image, (d) a green fluorescence image, and (f) a red fluorescence image of live E.coli 
cells stained with the viability assay mixture. 
green detection channel.   
In order to reduce this effect, the green optical filter was changed to the one with 
narrower band pass (500 ~ 530 nm). Below 530 nm, PI has negligible fluorescence 
intensity and 94% of the cells were scored as dead compared to 82 % for the 
 
(c) (d) 
(e) (f) 
(a) (b) 
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previous filter sets. Furthermore only 34 % of green signal was coincident with 
red signal compared to 96 %. 
5.3.3. CFDA and PI combination for bulk cytotoxicity staining 
Having established the staining conditions for live cells using a mixture of 6-
CFDA and GTA, a viability scoring assay combination, consisting of 6-CFDA, 
GTA, and PI, was tested in bulk. E.coli cells were cultured overnight in LB media 
within a shake incubator at 500 rpm and 37 °C. Dead cells were prepared by 
treating cells with methanol. Then live and dead cells were resuspended in PBS 
and stained with 2 µM 6-CFDA, 1 g/l GTA, and 4 µM PI for 20 minutes. 
Fluorescence images were then taken using an inverted fluorescence microscope, 
Olympus BX 51, with 495 nm excitation source. Figure 5.14 shows the 
transmission and fluorescence images of live and dead cells stained using the 
viability assay mixture. Dead cells only exhibit red fluorescence while live cells 
exhibit only green fluorescence as expected. The background is also fluorescent 
due to 6-CFDA within the solution and achieving good signal to noise ratio would 
be essential for successful viability scoring within microfluidic devices. 
The viability assays were also tested in micro-well plates for bulk viability 
scoring. The cells were prepared as explained previously and the optical densities 
of live and dead cells were matched to 1.15. After preparation of E.coli cell 
samples containing different ratios of dead and live cells, they were stained with 
the viability assay mixture for 20 minutes. As shown in Figure 5.15(a), red/green 
ratio increases linearly with increasing dead cell proportions within the sample. 
It should be noted that green background fluorescence intensity remained almost 
the same for all the samples. This is because 6-CFDA is inherently fluorescent 
and exhibits high background signals for both live and dead cells. Also esterase 
from dead cells may leak out to the media causing increase in the background 
fluorescence. In fact, when the dead cells were incubated with 6-CFDA over 1 
hour, higher background signals were observed due to esterase activity within 
the medium. 
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Figure 5.15.  (a) Wellplate and (b) microfluidic characterization of E.coli viability scoring using 6-
CFDA, PI, and GTA. 
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Stained E.coli cell samples were also introduced into a simple T-junction 
microfluidic device and encapsulated within droplets for viability scoring. The 
results show good correlation between the microfluidic and well-plate based 
detection methods.  
5.3.4. On-chip Microfluidic Viability Scoring 
Having successfully tested the viability assay combination in bulk conditions, 
they were tested within fully integrated droplet based microfluidic device. Briefly, 
the microfluidic device consists of four main modules for performing viability 
scoring on-chip. 
(i) Droplets containing various mixtures of dead and live E.coli cells (Optical 
density: 0.8, 150 pL-volume) were reinjected via reinjection nozzle and spaced out 
evenly by an influx of oil. In parallel, fluorescent viability assay dyes, 4 µM CFDA, 
2 g/l GTA, and 8 µM PI, were encapsulated into 1.5 nL droplets (Fig. 5.16). 
 (ii) Droplets with cell suspensions were merged with those containing viability 
assay dyes using electrocoalescence (Fig. 5.16.B). This module consists of an 
expansion geometry overlaying a pair of parallel chromium-gold electrodes (which 
are 30 µm apart with an electrode width of 50 µm)  separated from the channel by 
a 3 µm thick dielectric PDMS layer to prevent inter-droplet contamination by 
electrode wetting. Using this system, droplet electrocoalescence was achieved 
using a 7 V square shaped AC electric field with 1 kHz oscillation frequency whilst 
maintaining a one-to-one droplet fusion ratio. 
 (iii) Fused droplets were then incubated in a delay line with large channel cross-
section, 1000 µm wide, 260 µm deep and 31 cm long, a geometry designed to 
reduce back-pressure (Fig. 5.16C). This approximately gives an incubation time of 
25 minutes for a total flow rate of 4 µl min-1 allowing the assay reaction to fully 
develop on-chip. Although wide channels induce droplet residence time dispersion, 
this was reduced significantly by using a higher droplet volume fraction. 
(iv) After incubation, the droplets passed through a fluorescence detection point 
with a shallower channel than the incubation channel for more sensitive detection  
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Figure 5.16.  Integrated microfluidic viability scoring device consisting of A. droplet reinjection, B. 
droplet electrocoalescence, C. droplet incubation, and D. fluorescence detection. 
 (Fig 5.16D). Two avalanche photodiode detectors coupled with a 488 nm laser 
excitation source were used to analyse the fluorescence traces from droplets. This 
system is capable of resolving single fluorophore events at frequencies in excess of 
50 kHz (9). Multilayer lithography was used in order to manufacture channels 
with different thicknesses within a single microfluidic device. (4)  
2 µM 6-CFDA, 1g/l GTA and 4 µM PI mixtures were successfully used within the 
microfluidic device to distinguish between dead and live cells and the 
fluorescence images of droplets containing both live (Figure 5.17.(a),(b)) and dead 
E.coli cells (Figure 5.17.(c),(d)) show robust performance of the viability assay on-
chip. Live cells exhibit only green fluorescence signals while dead cells exhibit red 
fluorescence signals within droplets and the natural fluorescence from 6-CFDA 
and PI provide appropriate background fluorescence signal which outline 
droplets from continuous phase. The droplet background fluorescence intensity 
can be used as indicators for robust one-to-one droplet electrocoalescence by 
measuring the viability assay concentration within merged droplets. The droplets  
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Figure 5.17.  Fluorescence images of live and dead E.coli cells stained with 6-CFDA, PI, and GTA 
within microdroplets in microfluidic devices. (a) A green and (c) a red fluorescence 
images of droplets containing live cells, (b) a green and (d) a red fluorescence images 
of droplets containing dead cells. 
have a radius of 70 µm while E.coli cells are typically around 1-2 µm in size as in 
Fig.5.17. No green fluorescence signals were observed for dead cells while no red 
fluorescence cell signals were observed for live cells. 
Fluorescence traces of droplets containing live (Fig.5.18.(a)) and dead cells 
(Fig.5.18(b)) stained with viability assay are shown for 0.5 seconds. As Fig.5.17 
indicate, the droplets are outlined by background viability assay fluorescence and  
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the confocal fluorescence traces show that only live cells show green fluorescence 
bursts (Fig. 5.18(a)) while dead cells just exhibit red fluorescence bursts (Fig. 
5.18(b)). Using an in-house Matlab program developed by Dr. Joshua Edel, 
mixtures of E.coli cell populations were quantitatively analyzed in order to test 
for the viability assay performance (Fig. 5.18(c)). The results show linear increase 
of experimental measurement of dead cell proportion (red fluorescence 
bursts/total fluorescence bursts) with increasing dead cell proportion. Around 20% 
dead cells were detected in the live cell sample which is in agreement with the 
results published in the literature (4). The assay shows high degree of specificity 
with only 1.9 % of the dead cells and 9.9 % of the live cells showing dual staining. 
Note that this performance is the combined efficiency of all the individual 
microfluidic modules including droplet generation, electrocoalescence, incubation 
and detection. Altogether, the results showed the successful integration of the 
different droplet modules into a single on-chip robust viability assay for 
integrated droplet based high throughput photosensitiser screening experiments.  
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Figure 5.18.   Confocal fluorescence traces for 0.5 second of the viability assay stained (a) live and 
(b) dead E.coli containing microdroplets. (c) On-chip microfluidic viability scoring 
device performance. 
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Chapter 6. High Throughput PDT Screening  
In this chapter, the photosensitiser (TBO) screening results against E.coli cells 
are presented. Firstly, photodynamic efficacy of TBO against E.coli cells was 
tested in bulk micro-well plate and assessed using conventional colony forming 
unit assays. The effects of light irradiation, TBO concentration, and dark toxicity 
on the photosensitiser cytotoxicity during photodynamic treatment were 
investigated. Furthermore, the E.coli viability in these samples was scored in the 
microfluidic fluorescence detection system in order to verify the microfluidic 
viability scoring performance. Finally, the integrated microfluidic platform was 
used to assess the effect of parameters such as dark toxicity, photosensitiser 
concentration, light dose and poor oxygenation. Final results were validated 
against conventional colony forming unit assays.  
6.1. Introduction to microfluidic photosensitiser screening  
Conventional antimicrobial treatments are becoming increasingly ineffective due 
to the emergence of multi-drug resistant bacterial strains (1-4). Photodynamic 
therapy (PDT) represents an efficacious treatment modality for  
 
 
 
 
 
 
 
 
Figure 6.1.  Photodynamic therapy mechanism. 
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localized microbial infections with a broad spectrum of action, efficient 
inactivation of multidrug-resistant bacteria, and low mutagenic potential (5). 
Specifically, PDT is ideally suited for the treatment of multi-drug resistant 
microbial infections since pathogens cannot readily develop resistance to PDT (1). 
Additionally, PDT can be targeted for the treatment of localised infections. 
Various parameters such as photosensitiser concentration, light dose and 
dissolved oxygen concentration need to be examined in order to fully characterise 
the photodynamic inactivation process. This is due to the fact that oxygen often 
plays an important role in the mechanism of the photodynamic inactivation as the 
excited photosensitizer reacts with molecular oxygen to produce highly cytotoxic 
singlet oxygen species (6).  The mechanism of action of these sensitizers is shown 
in Figure 6.1.  Understanding which pathway of inactivation is in operation for a 
particular sensitizer and pathogen is important for understanding the full range 
of sensitizer activity so that various parameters such as oxygen concentration can 
be tuned for each photosensitiser. Unfortunately, conventional cytotoxicity 
screening of photosensitisers against microbial organisms is a slow and laborious 
process requiring extensive culture comparison after incubation periods of 18 
hours (7). Accordingly, it is difficult to screen multiple parameters such as 
photosensitiser concentration, light dose, and the effect of poor oxygen supply in a 
high-throughput manner. Without methods for the rapid screening of 
photosensitiser toxicity, structure-activity relationships cannot be easily assessed.  
Given the multi-factorial nature of photosensitiser activity, and the relatively slow 
screening methodology afforded by standard colony forming unit (CFU) assays, 
and heartened by the ability of microfluidic systems to act as a screening platform 
for antibacterial agents (8), a modular droplet-based microfluidic platform was 
developed for performing high-throughput cytotoxicity screening of 
photosensitizing conditions against E.coli cells. The microfluidic platform allows a 
faster direct readout of the bacterial cell viability, and is capable of screening a 
range of experimental parameters that impact cell cytotoxicity in high-throughput 
manner and using extremely small quantities of reagents. Significantly, the 
platform integrates multiple operations including cell encapsulation, light 
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irradiation, droplet incubation, droplet reinjection, oxygen delivery and assay 
reagent injection by droplet merger.   This multi-parametric approach enables 
information about the efficacy, safety and effective dosage ranges of PDT 
sensitizers to be assayed against target organisms rapidly with multiple repeat 
readings and with access to data and variables inaccessible to other techniques.  
6.1.1. Screening System 
Toluidine Blue O (TBO) and E.coli top10 strains were used as the model system 
for the bulk and microfluidic screening experiments. TBO is a cationic 
phenothiazinium dye which has been widely examined for the inactivation of 
pathogenic microorganisms and has been shown to be effective against both 
Gram-negative and gram-positive bacteria including E.coli cells (8). A bright 
transmission light source (TH-4 200, Olympus Medical, UK) with power density 
of 177 mWcm-2 was used for light exposure purposes in all screening experiments. 
A white light source was used as it is possible to test other photosensitisers with 
different absorption wavelength ranges. Also, it has uniform light intensity for 
the exposure area which is important for obtaining reliable screening data. The 
exposure area is also large enough to irradiate the whole microfluidic chamber in 
order to simultaneously expose light on all the droplets. 
6.2. Bulk Photosensitiser screening results 
The phototoxicity and dark toxicity of TBO on E.coli cells was tested in 96 micro 
well-plates as shown in Figure 6.2. This provides reference points to which the 
droplet based microfluidic photosensitiser screening results can be compared to 
as well as verifying the photosensitiser efficacy on the E.coli cells prior to proof-
of-concept microfluidic experiments. 
Firstly, E.coli cells were suspended in PBS with optical density of 1. They were 
then aliquoted to 96 micro well-plates and TBO was added to the mixture at 
various concentrations (Figure 6.2). This was performed in a sterile hood in order 
to prevent contamination of the samples by other microorganisms. After 
incubating the cell and TBO mixture for 30 minutes in dark, the samples were  
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Figure 6.2.  Bulk antimicrobial photosensitiser screening process. 
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Figure 6.3.  Bulk TBO phototoxicity on E.coli cells using colony forming unit assay. (a) TBO 
concentration screening at light dose of 212.4 J cm
-2
. (b) Effects of light dose on the 
cytotoxicity of 1 µM (■) and 2 µM (●) TBO on E.coli cells. 
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then irradiated with light (177 mWcm-2) for up to 1 hour period. Then the 
exposed samples were diluted by 5 orders of magnitude and to yield 
approximately 10,000  cells/ml. 10 µl of the diluted samples were evenly plated on 
the agar plates and incubated within a 36 °C room for a day before counting the 
colony forming units. 
6.2.1. Concentration and light dose screening 
The effects of TBO concentration on the E.coli cell viability were tested using cfu 
assay (Figure 6.3.(a)). In order to assess the effects of TBO concentration, various 
TBO concentrations from 0 to 3000 nM were added to the E.coli cell populations. 
100 µl of each sample was aliquoted in the 96 well-plates and incubated under 
dark for 30 minutes. They were then exposed to a bright transmission light with 
power density of 177 mW cm-2 for 20 minutes. This gives light dose of 212.4 J cm-2. 
After light exposure, the cell viability within the samples was assessed using 
colony forming unit assay. After diluting each sample by 5 orders of magnitude, 
approximately 100 colony forming units were present within 10 µl of live cell 
populations. It was possible to estimate the cell viability within photosensitised 
samples by counting the number of bacterial cell colonies within each plated petri 
dish and comparing it with the number of colony forming units within live cell 
populations. Note that it is difficult to precisely estimate the number of dead cells 
present within the live cell populations as this method only measures the number 
of viable cells within the sample. The CFU assay result shows a characteristic 
sigmoidal dose-response curve with IC50 values of 1320 nM TBO at 212.4 J cm-2. 
Almost 99% of the cells were dead above 2 µM TBO.   
The effect of light dose on the TBO cytotoxicity was also investigated (Figure 
6.3.(b)). TBO concentrations were fixed to 1 µM and 2 µM, and 100 µl of E.coli and 
TBO mixtures were added to the 96 wellplates and incubated for 30 minutes. 
These mixtures were then exposed to different light dose from 0 to 425 J cm-2 by 
varying the irradiation time. After light exposure, they were plated on the agar 
petri dish for colony forming unit assay. As the light dose was increased, linear 
increases in the proportion of dead cells were observed for both 1 µM and 2 µM 
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TBO concentrations. Given the same light dose, 2 µM TBO was more potent than 
1 µM TBO and had a steeper light dose-response slope with IC50 values of 132 J 
cm-2 for 1 µM and 75 J cm-2 for 2 µM TBO. Both 1 µM and 2 µM TBO had no 
observable cytotoxicity on E.coli cells under dark conditions. 
6.2.2. Dark Toxicity 
Following the bulk photosensitiser screening experiments, the dark cytotoxicity 
of TBO was tested at wide range of concentrations from 0 to 15 mM as shown in 
Figure 6.4. E.coli cells were incubated in dark in presence of TBO for 4 hours 
before assessing the dark toxicity of TBO using cfu assay. At concentrations from 
0 µM to 25 µm, TBO had little effects on the cell viability with the overall cell 
viability remaining above 80 % of the live cell stock. At concentrations higher 
than 100 µM, the cell viability started decreasing logarithmically with dark 
toxicity IC50 value of 300 µM and more than 99% of cells were dead at 15 mM 
which is much higher than TBO concentrations tested for photocytotoxicity. 
 
 
 
 
 
 
 
 
 
Figure 6.4.  TBO dark toxicity for E.coli cells. 
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6.2.3. Bulk Treatment and microfluidic detection 
The bulk CFU based screening results were then cross-checked with microfluidic 
viability assay detection (Figure 6.5). For these experiments, the cells were 
treated with TBO and exposed to light as described before. After light exposure, 
the photosensitised samples were diluted by 20 times and viability assay, 
consisting of 10 µM SYTO-9, 4 µM PI, and 4 nM AF-488, was added to the 
mixture and incubated for 20 minutes in order to allow fluorescent staining of the 
cells. The mixtures were then transferred to 1 ml plastic syringes (BD Plastipak, 
USA) and injected into a microfluidic droplet generator for fluorescence detection. 
The microfluidic droplet generation device was pre-treated by flowing continuous 
phase for 30 minutes in order to prevent SYTO-9 adhesion to the channel walls 
as well as facilitating reliable droplet generation process. For microfluidic droplet 
generation, the aqueous phase was injected at 1 µl/min while the continuous 
phase was injected at 2 µl/min. 488 nm laser was used as the excitation source 
and 20x objective was used to focus the laser and collect fluorescence signals from 
droplets. 
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Figure 6.5.  The screening workflow of bulk photosensitiser treatment followed by microfluidic 
viability assay detection.  
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Figure 6.6.  Bulk TBO concentration and light dose screening results. (a) The effects of TBO 
concentration on the cytotoxicity of E.coli cells when exposed with light dose of 212.4 
J cm
-2
 were assessed using cfu assay (■) and microfluidic confocal fluorescence 
detection (●) using viability assay mixture consisting of 10 µM SYTO-9, 4 µM PI and 4 
nM AF-488. (b) The effects of various light doses on the cell viability were assessed 
using CFU assay and microfluidic detection. 1 µM  and 2 µM  TBO concentrations 
were used to investigate the effects of light dose on cell viability. 
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6.2.4. Concentration and light dose screening 
TBO concentrations and light dose conditions were screened using the 
microfluidic viability detection and compared with the results from CFU assay 
(Figure 6.6). Bulk concentration screening results show a few key differences 
between CFU assay and microfluidic detection (Fig. 6.6.(a)). For both CFU assay 
and microfluidic viability detection, light dose of 212.4 Jcm-2 was applied using a 
bright white light source. Firstly, the CFU assay is unable to estimate the precise 
proportion of dead cells especially for live cell sample while microfluidic viability 
detection indicates that approximately 20-30 % of the bacterial cells were scored 
dead within live cell populations. In the literature, 20% cell viability loss is 
attributed to shear stress during droplet formation process as observed here (9). 
Nonetheless, both cfu assay and microfluidic detection show characteristic 
sigmoidal dose response curves with IC50 values of 1.3 µM and 1 µM, respectively. 
More than 90% of cells were scored dead at 2 µM TBO for both detection methods. 
The effects of light dose on the photosensitiser cytotoxicity at 1 µM and 2 µM 
TBO concentrations were also investigated using cfu assay and microfluidic 
fluorescence detection (Fig.6.6(b)). For both 1 µM and 2 µM TBO concentrations, 
the results showed strong correlations between cfu and microfluidic scoring 
methods with very similar sigmoidal dose-response curves. For 2 µM TBO 
concentration, IC50 light dose of 65 Jcm-2 and 72.8 Jcm-2 were obtained for cfu 
assay and microfluidic fluorescence detection, respectively. For 1 µM TBO 
concentration, IC50 values were 145.6 Jcm-2 for cfu assay and 119.9 Jcm-2 for 
microfluidic scoring.  
6.3. The effects of droplet on photosensitiser activity 
Having validated the photosensitiser performance in bulk, the effects of 
encapsulating cells and photosensitisers within microdroplets on the TBO photo-
toxicity were tested using 1) well-plate based light exposure and 2) microfluidic 
chamber based light exposure. Well-plate based light exposure examines the 
effects of droplets on the photosensitiser efficacy while microfluidic chamber  
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Figure 6.7.  Microdroplet based photosensitiser screening using micro well-plates. 
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Figure 6.8.  The effect of light dose on the TBO phototoxicity within well-plate based light 
exposure system for 100 µl bulk solution (■) and 100 µl micro-emulsion (▲) 
containing 1 µM TBO. 
based light exposure screening examines the effect of exposing droplets within 
microfluidic chamber. 
6.3.1. Photosensitisation of E.coli cells within microdroplets in 96 wellplate 
Firstly, droplets containing cells and photosensitisers were generated using a two 
aqueous inlet microfluidic device.  The microfluidic device is 60 µm deep and 140 
pL droplets were generated at 650 Hz using 10 µl/min aqueous flow rate and 10 
µl/min oil flow rates. In order to keep the droplets stable, FC-40 oil with 1.8% EA’ 
surfactant was used as the continuous phase. 100 µl of the oil and droplets were 
collected in each of the 96 well-plates and incubated for 25 minutes in dark. After 
light exposure with the transmission light source, the emulsion was transferred 
to eppendorf tubes and FC-40 oil was added in order to dilute the surfactant 
concentration. Then the emulsion was broken by centrifuging at 2000 rpm for 10 
minutes. Then the broken emulsion mixtures containing photosensitised cells 
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were mixed with the Baclight viability assay, 10 µM SYTO-9, 4 µM PI, 4 nM AF-
488 in order to score dead and live cells using microfluidic confocal fluorescence 
detection setup. 
In order to test whether screening in microdroplets had any effects on the 
photodynamic inactivation of E.coli cells, we first collected microdroplets 
containing cells and 1 µM TBO, generated as described above, and exposed them 
to varying light doses in a 96 micro-well plate. The emulsion was then broken by 
centrifuging in FC-40 and treated with a viability assay. This was then compared 
with a bulk experiment under the same conditions where 100 µl solutions 
containing cells and 1 µM TBO were exposed to varying light doses in a 96 well 
micro titre plate and the viability scored using the same Baclight viability assay 
mixture. The results show a linear dependence of cell death with increasing light 
dose with a strong correlation between non-droplet and droplet based exposure 
methods with 50% of cells dead at light dose of 315 J cm-2 for bulk and 313 J cm-2 
for droplets (Fig. 6.8). 
6.3.2. The effect of microfluidic chamber on the photosensitiser screening 
Then the TPE based microfluidic chamber was evaluated for photosensitiser 
screening. Again, 140 pL droplets containing E.coli cells and 1 µM TBO were 
collected within the TPE microfluidic chamber for 5 minutes. After incubating 
the droplets within the chamber for 25 minutes in dark, droplets were exposed 
using the transmission light source (177 mWcm-2).  The emulsions were then 
collected in eppendorf tubes and broken by centrifuging. After staining the 
photosensitised cells using fluorescent viability assay, they were scored using a 
droplet based microfluidic viability scoring device.  
TPE microfluidic chambers with bottom substrate thicknesses of 1 mm and 3 mm 
were tested as the droplet light exposure module and compared with the results 
from micro well-plate based exposure system. A 1mm TPE strip has a high 
transmission of red light with transmittance value of over 90 % from 400 nm to 
800 nm (10). On the other hand, a 3 mm thick strip of TPE has ~ 70 % 
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transmittance and as a result, the microfluidic incubation chamber showed a 
reduced photosensitiser efficacy when exposed through the 3 mm thick TPE 
substrate. The IC50 values were 315 J cm-2, 310 J cm-2, and 449 J cm-2 for bulk, 1 
mm TPE substrate, and 3 mm TPE substrate, respectively (Fig. 6.9). When the 
experimental results were corrected for the actual light transmission value of 
70 %, it shows very similar results to the bulk screening results with similar 
dose-response curves and IC50 values of 310 J cm-2 for 1mm TPE substrate and 
314 J cm-2 for 3 mm TPE substrate.  
The TPE-based microfluidic chamber device showed robust performance as the 
light exposure module and were subsequently used during the light exposure step 
for the complete microfluidic screening platform. For the actual microfluidic 
screening experiments, 1 mm TPE substrate was used in order to minimize the 
correction for TPE light transmission instead of 3 mm TPE bottom substrate.  
 
 
 
 
 
 
 
 
 
 
Figure 6.9.  The effect of exposing light within TPE-based microfluidic chamber devices. The 
bottom substrate thicknesses of 1 mm (●), and 3 mm (■) were assessed and compared  
with light exposure on 100 µl bulk solution in well-plates (▲).  
 
157 
 
 
 
 
 
 
 
 
 
Figure 6.10.  Schematic of the droplet based microfluidic photosensitiser screening platform. A. 
E.coli cells and photosensitisers are encapsulated into droplets. B. Droplets are 
collected in a microfluidic TPE chamber for dark incubation and light exposure. C. 
Light exposed droplets are reinjected from the chamber into the viability scoring device. 
D. Two aqueous droplets, the smaller droplet containing cells and photosensitiser and 
the larger one containing the viability assay mixture, are merged using AC-electric field. 
E. Fused droplets are then incubated within a delay line for 25 minutes before 
fluorescence detection. Scale bars indicate 50 µm. 
6.4. Integrated microfluidic platform for photosensitiser screening 
Then, a modular, droplet-based microfluidic platform was used for performing 
high-throughput cytotoxicity screening of photosensitising conditions against 
E.coli cells. The microfluidic system is capable of screening a range of 
experimental parameters that impact cell cytotoxicity in high-throughput 
manner and using extremely small quantities of reagents. Significantly, the 
platform integrates multiple operations including cell encapsulation, light 
irradiation, droplet incubation, droplet reinjection, oxygen delivery and assay 
reagent injection by droplet merger. This multi-parametric approach enables 
information about the efficacy, safety and effective dosage ranges of PDT 
sensitizers to be assayed against target organisms rapidly with multiple repeat 
readings and with access to data and variables inaccessible to other techniques.  
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The platform consists of three in-line microfluidic devices. The first of these 
devices allows the encapsulation of cells and the sensitizer Toluidine blue O (TBO) 
in pico-litre sized compartments (Fig. 6.10.A). The second device allows the 
incubation and simultaneous irradiation of millions of these droplets (Fig. 6.10.B), 
and the third enables on-chip viability scoring of the exposed samples (Fig. 6.10.C, 
D, E). The first and third devices were fabricated using PDMS by standard soft 
lithography protocols.  The second microfluidic device (Fig. 6.10.B) used for 
incubation and light irradiation is made out of thermoset polyester (TPE).   
In the first microfluidic device, a suspension of Escherichia coli cells and TBO 
solutions were pumped separately through the two aqueous inlets. A T-junction 
geometry (Fig. 6.10.A) was employed to encapsulate cells and photosensitizers in 
140 pL droplets in FC-40 oil (Fluorinert, 3M, Minnesota) with 1.8 % of a custom 
synthesized PEG-PFPE triblock biocompatible perfluorinated surfactant. Each 
microdroplet contained around 20 E.coli cells as determined using the traditional 
CFU counting method. 
These droplets were then collected in the second microfluidic device where they 
are either incubated in the dark or incubated with light irradiation (Fig. 6.10.B). 
Within this device, millions of droplets can be stored in the dark or exposed to 
light simultaneously for several hours to days and then reinjected into another 
device for further processing by pumping carrier oil. The incubation chamber 
within this microfluidic device (4 mm X 2 mm X 260  m) is fabricated using TPE.  
In order to minimize the expansion and distortion of the device during reinjection 
process, a pillar with 5.15 mm radius was incorporated in the centre of the 
chamber to provide a solid support. Because TPE has a large Young’s modulus 
value (3.8 GPa) compared to PDMS (~4 MPa) (11), the large chamber remains 
rigid and stable. Droplets can be completely loaded within a few minutes into the 
chamber using high flow rates (20 µl/min – 40 µl/min) and reinjected into another 
device without significant expansion (Fig. 6.10.C). Furthermore, multiple 
microfluidic chambers can be fabricated and used for light exposure which allows 
the screening of different light exposure conditions in a parallel fashion. After 
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incubation within the chamber structure, droplets were re-injected into the third 
microfluidic device for viability scoring.  
The viability scoring device consists of four main modules:  
(i) The photosensitised, cell-containing droplets are re-injected into the 
microfluidic device via a reinjection nozzle and spaced out evenly by an influx of 
oil (Fig. 6.10.C). In parallel, fluorescent viability assay dyes are encapsulated into 
1.5 nL droplets at 10-20 Hz frequency. 
 (ii) Droplets with cell suspensions are merged with those containing viability 
assay dyes using electrocoalescence (Fig. 6.10.D). This module consists of an 
expansion geometry overlaying a pair of parallel chromium-gold electrodes 
(which are 30 µm apart with an electrode width of 50 µm)  separated from the 
channel by a 3 µm thick dielectric PDMS layer to prevent inter-droplet 
contamination by electrode wetting. Using this system, droplet electrocoalescence 
was achieved using a 7 V square shaped AC electric field with 1 kHz frequency 
whilst maintaining a one-to-one droplet fusion ratio. 
 (iii) Fused droplets are then incubated in a delay line with large channel cross-
section, 1000 µm wide, 260 µm deep and 31 cm long, a geometry designed to 
reduce back-pressure (Fig. 6.10.E). This approximately gives an incubation time 
of 25 minutes for a total flow rate of 4 µl min-1 allowing the assay reaction to fully 
develop on-chip. Although wide channels induce droplet residence time dispersion, 
this was reduced significantly by using a higher droplet volume fraction. 
 (iv) After incubation, the droplets pass through a fluorescence detection point 
with a shallower channel than the incubation channel for more sensitive 
detection. Two avalanche photodiode detectors coupled with a 488 nm laser 
excitation source were used to analyse the fluorescence traces from droplets. This 
system is capable of resolving single fluorophore events at frequencies in excess 
of 50 kHz. Multilayer lithography was used in order to manufacture channels 
with different thicknesses within a single microfluidic device. (9)  
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The viability scoring chip operates at a throughput of 10 – 20 Hz which 
potentially allows for the screening of over a million separate reaction conditions 
with a viability assay volume of 1.5 nL per droplet. The total volume of 4.5 µl per 
each assay point compared to 100 µL for microwell plate based measurements. 
Notably, this system allows one to perform the microfluidic screening by using 
only 450 nL of the cell and photosensitizer suspensions which is highly beneficial 
for screening photodynamic activity for expensive state-of-the-art 
photosensitizers. 
6.4.1. The effect of oxygen on photosensitising efficacy and dark toxicity 
Oxygen plays an important role in the mechanism of the photodynamic 
inactivation as the excited photosensitizer reacts with molecular oxygen to 
produce highly cytotoxic singlet oxygen species (6). Understanding which 
pathway of inactivation is in operation for a particular sensitizer and pathogen is 
important for understanding the full range of sensitizer activity so that various 
parameters such as oxygen concentration can be tuned for each photosensitiser. 
The droplet based microfluidic photosensitiser screening platform provides an 
excellent platform for screening the oxygen condition through the use of 
continuous fluorinated oil phase (FC-40) with very high oxygen dissolution 
capacity and TPE based microfluidic chamber for light exposure. Perfluorinated 
oils have very high maximum oxygen dissolution content (15 mM for FC-40) 
compared to 2.2 mM in water (12). In fact, these oils can dissolve so much oxygen 
that rats have been shown to be able to breathe the oxygen saturated 
perfluorinated liquids for hours and still survive (13). Furthermore, FC-40 has 
been shown to allow rapid oxygen exchange between oil and aqueous droplets in 
microfluidic systems (14). Thus, it serves as an ideal continuous carrier phase for 
delivering the oxygen needed for the photodynamic inactivation of E.coli cells. 
TPE material is impermeable to oxygen and allows more facile control of oxygen 
content through the perfusion of oxygen saturated FC-40 through the device 
during light exposure. 
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Figure 6.11.  On-chip photosensitiser concentration, oxygen content and dark toxicity screening 
using the microfluidic screening workflow. The effects of TBO concentration on E.coli 
cytotoxicity are investigated at a light dose of 212.4 J cm
-2
 with (●) and without 
perfusion of the oxygenated oil (■). Significantly different dose-response curve and 
IC50 values were generated with greater phototoxicity with perfusion of oxygenated oil. 
Dark toxicity (▲) of TBO across the same concentrations used for light exposure 
experiments. 
In order to screen for the oxygen concentration, FC-40 with 1.8 % 
perfluorosurfactant was fully saturated with oxygen by sparging oxygen through 
it for an hour and immediately used for droplet generation. A 2.5 ml gastight 
syringe was used to deliver fully oxygenated FC-40 through PEEK tubing to the 
microfluidic devices to minimize the leakage of oxygen gas to the atmosphere.   
Droplets were then incubated for an hour within TPE microfluidic device in the 
dark in a 37 °C oven prior to light exposure step in order to allow TBO uptake by 
E.coli cells. Droplets were then exposed to a white transmission light with a 
power density of 177 mW cm-2 for 20 minutes giving a total light dose of 212.4 J 
cm-2. During the light irradiation, FC-40 with 1.8 % surfactant, fully saturated 
with oxygen, was continuously perfused through the chamber at a flow rate of 10 
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µl min-1 in order to provide continuous supply of oxygen. As FC40 has a higher 
density of 1.87 gL-1 compared to water (1 gL-1), droplets were kept within the 
microfluidic light exposure chamber by slightly tilting the device by 7° so that the 
gravity would help to counterbalance the hydrodynamic drag force and prevent 
droplets from exiting the chamber along with the oil flow. Light exposed droplets 
containing E.coli cells were then reinjected into the viability scoring chip for on-
chip viability scoring.  
Figure 6.11 shows the effect of perfusing oxygenated oil through the microfluidic 
chamber device during the light irradiation step. The effect of different 
concentrations of TBO under the same light dose of 212.4 J cm-2 was screened by 
exposing droplets within the microfluidic chamber structure with and without 
perfusion of the oxygenated oil. Without perfusion, the cell viability decreased 
more gradually with TBO concentration than with perfusion. In fact, the cells 
were almost all dead at TBO concentration of over 5 µM without perfusion 
whereas only 2 µM TBO was required when the oxygenated oil was perfused 
through the device during light irradiation (Fig. 6.11). Significantly different IC50 
values were found under these different conditions with values of 1.94 µM 
without perfusion and 1.10 µM with oxygenated oil perfusion (Fig. 6.11). When 
these values were compared with the bulk screening results, microfluidic results 
showed a strong correlation with the bulk results when oxygenated FC-40 oil was 
perfused through the device. Without perfusion of FC-40 through the device, 
oxygen is depleted from the droplets rapidly during the light exposure step and 
the TBO oxygen impermeability does not allow any influx of oxygen through the 
device. As the formation of singlet oxygen is vital to the TBO cytotoxicity, the 
depletion of oxygen lowers the photosensitiser efficacy on the E.coli cells. 
Although more detailed analysis is required in order to assess the effect of the 
oxygen content on the TBO phototoxicity, the initial results show significant 
differences between perfusion and non-perfusion of oxygenated oil through the 
device on the TBO cytotoxicity. 
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In addition, no cytotoxic effect of TBO on E.coli cells was observed when the 
droplets containing cells and TBO were incubated for 80 minutes within the 
microfluidic chamber under dark conditions with average dead cell percentage of 
around 20 % across the whole TBO concentration range (Fig. 6.11). 
6.4.2. Comparison with bulk screening results using conventional cfu assay 
In order to properly assess the robustness of high-throughput screening platform, 
the microfluidic dose-response curves were compared with that obtained from 
bulk well-plate based photosensitiser screening experiments assessed with a 
conventional colony forming unit assay (CFU) read-out. The results showed 
strong correlation between the CFU and microfluidic based screening systems 
with the 80 % cell viability limit in the droplet-based microfluidic results 
explained by the 10-20 % loss of cell viability during cell encapsulation process 
(Fig. 6.12). Also it is important to note that it was not possible to estimate the  
 
 
 
 
 
 
 
 
 
Figure 6.12  On-chip photosensitiser concentration screening using the microfluidic screening 
workflow. Comparison of the microfluidic TBO concentration screening (■) with the 
bulk photosensitiser screening results from cfu assay (●) at light dose of 212.4 J cm
-2
. 
Both screening results show similar dose-response curves and IC50 values. 
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exact proportion of dead cells within the control live cell population using colony 
forming unit assay as the CFU assay relies on culture comparisons between 
different conditions where live cell population itself is the control sample. It is 
noteworthy to mention that each microfluidic data point is an average coming 
from 3000 cells. All in all, the microfluidic photosensitiser screening platform 
shows a strong correlation to the bulk cfu assay with sigmoidal dose response 
curves with IC50 value of 1.09 µM for microfluidics and 1.32 µM for bulk 
measurements (Fig. 6.12). 
6.4.3. Light Exposure Screening  
The effect of light dose on cell viability was also studied using this microfluidic 
screening system and compared with the bulk results (Fig. 6.13). In this 
experiment, the TBO concentration was fixed to 1 µM and different light doses 
were applied by varying the irradiation time with 177 mW cm-2 transmission 
light source. Again, the droplets containing cells and 1 µM TBO were incubated  
 
 
 
 
 
 
 
 
 
Figure 6.13.  On-chip light dose screening with droplets containing E.coli cells (A
600nm
 ~ 0.25) and 1 
µM TBO. The microfluidic results (■) were compared with the bulk cfu screening 
results (●). 
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in the dark for an hour and exposed to varying light doses within the microfluidic 
chamber. As the light dose was increased, a linear increase in the proportion of 
dead cells was observed with over 90 % of the cells dead at 510 J cm-2 for 
microfluidic and 470 J cm-2 for bulk (Fig. 6.13). The light dose IC50 values were 
250 J cm-2 for on-chip screening and 150 J cm-2 for bulk cfu screening result (Fig. 
6.12). From the figure, it can be seen that 1 µM TBO had no measurable 
cytotoxicity without any light exposure with 20 % of the cells scored dead for on-
chip microfluidic screening result as before.  
6.4.4. On-chip screening summary 
The droplet based microfluidic system capable of screening the effects of 
concentration, light dose, and oxygen content on PDT efficiency and also capable 
of assessing sensitizer dark toxicity has been successfully developed. Proof of 
concept microfluidic screening performance was compared with the conventional 
CFU assay and was shown to have a strong correlation. 
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Chapter 7. Conclusion and Outlook 
In this chapter, the key achievements are presented and discussed. Future 
improvements on the project are suggested and a discussion of the prospect of the 
high throughput microfluidic platform is given. 
7.1. Summary of achievements  
Droplet based microfluidic systems have attracted considerable attention due to 
their unique advantages for performing high throughput screening experiments 
(1, 2). These advantages include the ability to generate (3-5) and manipulate 
thousands of droplets per second (4, 6-9), encapsulate and compartmentalise 
individual cells or biomolecules (10-13), and analyze the droplets efficiently using 
state-of-the-art detection systems (14-17). Although it is possible to generate, 
manipulate and analyze microdroplets flowing through a microfluidic device, the 
integration of various functional modules for performing high throughput 
screening has been a major challenge. In this thesis, a microfluidic platform was 
developed for analyzing the cytotoxic effects of photosensitisers against microbial 
cells. Various parameters such as dissolved oxygen contents, photosensitiser 
concentrations, light exposure and dark toxicity were screened using the 
developed platform. 
In order to successfully carry out complicated reaction schemes in droplet based 
microfluidic platform, it was essential to have a surfactant that is able to reliably 
generate droplets, stabilise the droplets against coalescence and flocculation, and 
perform biochemical experiments without any cytotoxic effects. As commercial 
surfactants do not have sufficient characteristics for high throughput screening 
microfluidic platform, a perfluorinated PFPE-PEG-PFPE tri-block copolymer 
surfactant was synthesized and tested extensively. The droplets generated using 
the continuous phase consisting of 2% w/v of the surfactant and FC-40 oil were 
found to be stable against coalescence over 3 weeks, lipophobic, and have 
minimal effect on the E.coli viability for over 5 days. 
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Droplet generation process was characterised in detail using a Phantom v649 
high speed CCD camera (Vision Research, USA) in order to perform high 
throughput screening experiments with controlled droplet generation frequency 
and size. Total flow rates between 0 to 8 µl/min were investigated at water 
fraction range of 0.1 to 0.5. Also, the effect of the viscosity on the droplet 
generation process was investigated by testing various oil/surfactant mixtures. It 
was found that the droplet size generally increased with increasing water 
fraction, and decreased with increasing total flow rates. Droplet frequency 
increased with increasing total flow rates while water fraction had smaller effect 
on the droplet frequency. Consistently larger droplets were formed when 
continuous phase with low viscosity was used for droplet generation.  
Individual modules for the microfluidic screening platform were developed and 
integrated together in order to perform complicated photosensitiser screening 
experiments. Firstly, the T-junction droplet generation module capable of 
generating 140 pL sized droplets at 650 Hz was designed and tested for facile 
droplet generation. Then a TPE microfluidic chamber was developed for light 
exposure purposes. In this chamber, millions of droplets can be stored for hours 
with minimal cytotoxic effects to cells, exposed to varying light doses, and 
reinjected to other microfluidic device for further processing. For viability scoring, 
an integrated microfluidic device capable of generation and reinjection of droplets, 
electrocoalescence, incubation of droplets for 20~30 minutes and fluorescence 
detection was designed and developed. Finally, all the individual components 
were put together to perform complicated experiment. 
Then a suitable viability assay was found capable of performing cytotoxicity 
screening experiments for photodynamic therapy. The viability assay comprising 
of 6-CFDA, Propidium Iodide and Glutaraldehyde was compatible with the 
oil/surfactant mixture, and had strong enough fluorescence signal so that cells 
could be detected with sufficient sensitivity. In fact the assay showed high degree 
of specificity with 1.9% of the dead cells and 9.9% of the live cells showing dual 
staining. 
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Finally, the microfluidic platform was used to screen Toluidine blue O 
phototoxicity against top10 E.coli cells. Various parameters such as TBO 
concentration, light dose, dark toxicity and dissolved oxygen were investigated 
using the microfluidic platform and compared with conventional cfu method. The 
results showed a strong correlation between microfluidic and conventional 
screening method. 
7.2. Future works and improvements 
The development of photosensitiser screening platform described in this thesis 
demonstrates that microfluidic platform is capable of performing complicated 
high throughput screening experiments whilst integrating various functional 
modules. In addition, the comparison of the microfluidic and conventional cfu 
method hints at the reliability of the microfluidic system for performing biological 
experiments on-chip. 
For large scale industrial applications, it is essential to perform such complicated 
experiments with very high throughput and in combinatorial manner. As such, it 
is essential to find a method of coding droplets so that the droplet content can be 
correlated with the cytotoxicity screening results. To this end, various detection 
schemes such as SERS (15, 18, 19), electrochemical detection (20), fluorescence 
(14) and fluorescence polarisation detection (16) were used in droplet based 
microfluidic studies and can be incorporated within the platform to allow 
multidimensional and combinatorial analysis of the cytotoxic effects (2). For 
fluorescence coding schemes, a colour filter may be used to minimize the 
photobleaching effect for the coding fluorescent materials. 
In addition, to allow in-depth biological analysis of the photodynamic process, it 
would be worthwhile to encapsulate single cells within a single droplet and 
perform high throughput screening. This would allow various advantages over 
conventional screening system as it is possible to see the effects of the 
photosensitiser on single rather than multiple cells. As the droplets can be sorted, 
it may be possible to perform directed evolution of the photodynamic effect to 
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gain insight on the evolutionary process taking place within microbial population 
against photosensitising effect and validate the claims that microbial cells do not 
readily develop resistance against photodynamic treatment.  
7.3. Future Outlook 
Although droplet based microfluidic technology is still in the early stage, many 
enabling technologies were demonstrated by various research groups (2, 16, 21-
23). In addition, several high throughput screening applications were also shown 
using complicated microfluidic platforms (22), optical droplet coding strategy (2), 
and robotic sample delivery system. With the ability to generate, manipulate and 
analyze droplets at kHz frequencies, throughput of over 107 experiments per day 
is possible.  
With ongoing development and activities in the droplet based microfluidic field, 
more advanced modules and functionalities will be developed and integrated. 
When these techniques are integrated together, experiments that were not 
possible within conventional screening platform would be possible with high 
degree of specificity and control. Droplet based microfluidics hold great promises 
for high throughput screening applications and will make a big impact on 
practical applications for chemical and biological sciences.  
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